Basics of study design: Practical considerations

Article Type
Changed
Mon, 10/01/2018 - 14:35
Display Headline
Basics of study design: Practical considerations
From the “Biostatistics and Epidemiology Lecture Series, Part 1”

INTRODUCTION

Basic research skills are not acquired from medical school but from a mentor.1,2 A mentor with experience in study design and technical writing can make a real difference in your career. Most good mentors have more ideas for studies than they have time for research, so they are willing to share and guide your course. Your daily clinical experience provides a wealth of ideas in the form of “why do we do it this way” or “what is the evidence for” or “how can we improve outcomes or cut cost?” Of course, just about every study you read in a medical journal has suggestions for further research in the discussion section. Finally, keep in mind that the creation of study ideas and in particular, hypotheses, is a mysterious process, as this quote indicates: “It is not possible, deliberately, to create ideas or to control their creation. What we can do deliberately is to prepare our minds.” 3 Remember that chance favors the prepared mind.

DEVELOPING THE STUDY IDEA

Often, the most difficult task for someone new to research is developing a practical study idea. This section will explain a detailed process for creating a formal research protocol. We will focus on two common sticking points: (1) finding a good idea, and (2) developing a good idea into a problem statement.

Novice researchers with little experience, no mentors, and short time frames are encouraged not to take on a clinical human study as the principle investigator. Instead, device evaluations are a low-cost, time-efficient alternative. Human studies in the form of a survey are also possible and are often exempt from full Institutional Review Board (IRB) review. Many human-like conditions can be simulated, as was done, for example, in the study of patient-ventilator synchrony.4,5 And if you have the aptitude, whole studies can be based on mathematical models and predictions, particularly with the vast array of computer tools now available.6,7 And don’t forget studies based on surveys.8

A structured approach

A structured approach for developing a formal research protocol.
Figure 1. A structured approach for developing a formal research protocol.

A formal research protocol is required for any human research. However, it is also recommended for all but the simplest investigations. Most of the new researchers I have mentored take a rather lax approach to developing the protocol, and most IRBs are more interested in protecting human rights than validating the study design. As a result, much time is wasted and sometimes an entire study has to be abandoned due to poor planning. Figure 1 illustrates a structured approach that helps to ensure success. It shows a 3-step, iterative process.

The first step is a process of expanding the scope of the project, primarily through literature review. Along the way you learn (or invent) appropriate terminology and become familiar with the current state of the research art on a broad topic. For example, let’s suppose you were interested in the factors that affect the duration of mechanical ventilation. The literature review might include topics such as weaning and patient-ventilator synchrony as well as ventilator-associated pneumonia. During this process, you might discover that the topic of synchrony is currently generating a lot of interest in the literature and generating a lot of questions or confusion. You then focus on expanding your knowledge in this area.

In the second step, you might develop a theoretical framework for understanding patient-ventilator synchrony that could include a mathematical model and, perhaps, an idea to include simulation to study the problem.

In the third step, you need to narrow the scope of the study to a manageable level that includes identifying measurable outcome variables, creating testable hypotheses, considering experimental designs, and evaluating the overall feasibility of the study. At this point, you may discover that you cannot measure the specific outcome variables indicated by your theoretical framework. In that case, you need to create a new framework for supporting your research. Alternatively, you may find that it is not possible to conduct the study you envision given your resources. In that case, it is back to step 1.

Eventually, this process will result in a well-planned research protocol that is ready for review. Keep in mind that many times a protocol needs to be refined after some initial experiments are conducted. For human studies, any changes to the protocol must be approved by the IRB.

The problem statement rubric

The most common problem I have seen novices struggle with is creating a meaningful problem statement and hypothesis. This is crucial because the problem statement sets the stage for the methods, the methods yield the results, and the results are analyzed in light of the original problem statement and hypotheses. To get past any writer’s block, I recommend that you start by just describing what you see happening and why you think it is important. For example, you might say, “Patients with acute lung injury often seem to be fighting the ventilator.” This is important because patient-ventilator asynchrony may lead to increased sedation levels and prolonged intensive care unit stays. Now you can more easily envision a specific purpose and testable hypothesis. For example, you could state that the purpose of this study is to determine the baseline rates of different kinds of patient-ventilator synchrony problems. The hypothesis is that the rate of dyssynchrony is correlated with duration of mechanical ventilation.

Here is an actual example of how a problem statement evolved from a vague notion to a testable hypothesis.

Original: The purpose of this study is to determine whether measures of ineffective cough in patients with stroke recently liberated from mechanical ventilation correlate with risk of extubation failure and reintubation.

Final: The purpose of this study is to test the hypothesis that use of CoughAssist device in the immediate post-extubation period by stroke patients reduces the rate of extubation failure and pneumonia.

The original statement is a run-on sentence that is vague and hard to follow. Once the actual treatment and outcome measures are in focus, then a clear hypothesis statement can be made. Notice that the hypothesis should be clear enough that the reader can anticipate the actual experimental measures and procedures to be described in the methods section of the protocol.

Here is another example:

Original: The purpose of this study is to evaluate a device that allows continuous electronic cuff pressure control.

Final: The purpose of this study is to test the hypothesis that the Pressure Eyes electronic cuff monitor will maintain constant endotracheal tube cuff pressures better than manual cuff inflation during mechanical ventilation.

The problem with the original statement is that “to evaluate” is vague. The final statement makes the outcome variable explicit and suggests what the experimental procedure will be.

This is a final example:

Original: Following cardiac/respiratory arrest, many patients are profoundly acidotic. Ventilator settings based on initial arterial blood gases may result in inappropriate hyperventilation when follow-up is delayed. The purpose of this study is to establish the frequency of this occurrence at a large academic institution and the feasibility of a quality improvement project.

Final: The primary purpose of this study is to evaluate the frequency of hyperventilation occurring post-arrest during the first 24 hours. A secondary purpose is to determine if this hyperventilation is associated with an initial diagnosis of acidosis.

Note that the original statement follows the rubric of telling us what is observed and why it is important. However, the actual problem statement derived from the observation is vague: what is “this occurrence” and is the study really to establish any kind of feasibility? The purpose is simply to evaluate the frequency of hyperventilation and determine if the condition is associated with acidosis.

 

 

EXAMPLES OF RESEARCH PROJECTS BY FELLOWS

The following are examples of well-written statements of study purpose from actual studies conducted by our fellows.

Device evaluation

Defining “Flow Starvation” in volume control mechanical ventilation.

  • The purpose of this study is to evaluate the relationship between the patient and ventilator inspiratory work of breathing to define the term “Flow Starvation.”

Auto-positive end expiratory pressure (auto-PEEP) during airway pressure release ventilation varies with the ventilator model.

  • The purpose of this study was to compare auto-PEEP levels, peak expiratory flows, and flow decay profiles among 4 common intensive care ventilators.

Patient study

Diaphragmatic electrical activity and extubation outcomes in newborn infants: an observational study.

  • The purpose of this study is to describe the electrical activity of the diaphragm before, during, and after extubation in a mixed-age cohort of preterm infants.

Comparison of predicted and measured carbon dioxide production for monitoring dead space fraction during mechanical ventilation.

  • The purpose of this pilot study was to compare dead space with tidal volume ratios calculated from estimated and measured values for carbon dioxide production.

Practice evaluation

Incidence of asynchronies during invasive mechanical ventilation in a medical intensive care unit.

  • The purpose of this study is to conduct a pilot investigation to determine the baseline incidence of various forms of patient-ventilator dyssynchrony during invasive mechanical ventilation.

Simulation training results in improved knowledge about intubation policies and procedures.

  • The purpose of this study was to develop and test a simulation-based rapid-sequence intubation curriculum for fellows in pulmonary and critical care training.

HOW TO SEARCH THE LITERATURE

After creating a problem statement, the next step in planning research is to search the literature. The 10th issue of Respiratory Care journal in 2009 was devoted to research. Here are the articles in that issue related to the literature search:

  • How to find the best evidence (search internet)9
  • How to read a scientific research paper10
  • How to read a case report (or teaching case of the month)11
  • How to read a review paper.12

I recommend that you read these papers.

Literature search resources

My best advice is to befriend your local librarian.13 These people seldom get the recognition they deserve as experts at finding information and even as co-investigators.14 In addition to personal help, some libraries offer training sessions on various useful skills.

PubMed

The Internet resource I use most often is PubMed (www.ncbi.nlm.nih.gov/pubmed). It offers free access to MEDLINE, which is the National Library of Medicine’s database of citations and abstracts in the fields of medicine, nursing, dentistry, veterinary medicine, health care systems, and preclinical sciences. There are links to full-text articles and other resources. The website provides a clinical queries search filters page as well as a special queries page. Using a feature called “My NCBI,” you can have automatic e-mailing of search updates and save records and filters for search results. Access the PubMed Quick Start Guide for frequently asked questions and tutorials.

SearchMedica.com

The SearchMedica website (www.searchmedica.co.uk) is free and intended for medical professionals. It provides answers for clinical questions. Searches return articles, abstracts, and recommended medical websites.

Synthetic databases

There is a class of websites called synthetic databases, which are essentially prefiltered records for particular topics. However, these sites are usually subscription-based, and the cost is relatively high. You should check with your medical library to get access. Their advantage is that often they provide the best evidence without extensive searches of standard, bibliographic databases. Examples include the Cochrane Database of Systematic Reviews (www.cochrane.org/evidence), the National Guideline Clearinghouse (www.guideline.gov), and UpToDate (www.uptodate.com). UpToDate claims to be the largest clinical community in the world dedicated to synthesized knowledge for clinicians and patients. It features the work of more than 6,000 expert clinician authors/reviewers on more than 10,000 topics in 23 medical specialties. The site offers graded recommendations based on the best medical evidence.

Portals

Portals are web pages that act as a starting point for using the web or web-based services. One popular example is ClinicalKey (www.clinicalkey.com/info), formerly called MD Consult, which offers books, journals, patient education materials, and images. Another popular portal is Ovid (ovid.com), offering books, journals, evidence-based medicine databases, and CINAHL (Cumulative Index to Nursing and Allied Health Literature).

Electronic journals

Many medical journals now have online databases of current and archived issues. Such sites may require membership to access the databases, so again, check with your medical library. Popular examples in pulmonary and critical care medicine include the following:

Electronic books

Amazon.com is a great database search engine for books on specific topics. It even finds out-of-print books. And you don’t have to buy the books, because now you can rent them. Sometimes, I find what I wanted by using the “Look Inside” feature for some books. Note that you can look for books at PubMed. Just change the search box from PubMed to Books on the PubMed home page. Of course, Google also has a book search feature. A great (subscription) resource for medical and technical books is Safari (https://www.safaribooksonline.com). Once again, your library may have a subscription.

General Internet resources

You probably already know about Google Scholar (scholar.google.com) and Wikipedia.com. Because of its open source nature, you should use Wikipedia with caution. However, I have found it to be a very good first step in finding technical information, particularly about mathematics, physics, and statistics.

 

 

Using reference management software

One of the most important things you can do to make your research life easier is to use some sort of reference management software. As described in Wikipedia, “Reference management software, citation management software or personal bibliographic management software is software for scholars and authors to use for recording and using bibliographic citations (references). Once a citation has been recorded, it can be used time and again in generating bibliographies, such as lists of references in scholarly books, articles, and essays.” I was late in adopting this technology, but now I am a firm believer. Most Internet reference sources offer the ability to download citations to your reference management software. Downloading automatically places the citation into a searchable database on your computer with backup to the Internet. In addition, you can get the reference manager software to find a PDF version of the manuscript and store it with the citation on your computer (and/or in the Cloud) automatically.

But the most powerful feature of such software is its ability to add or subtract and rearrange the order of references in your manuscripts as you are writing, using seamless integration with Microsoft Word. The references can be automatically formatted using just about any journal’s style. This is a great time saver for resubmitting manuscripts to different journals. If you are still numbering references by hand (God forbid) or even using the Insert Endnote feature in Word (deficient when using multiple occurrences of the same reference), your life will be much easier if you take the time to start using reference management software.

The most popular commercial software is probably EndNote (endnote.com). A really good free software system with about the same functionality as Zotero (zotero.com). Search for “comparison of reference management software” in Wikipedia. You can find tutorials on software packages in YouTube.

STUDY DESIGN

Schematic of pre-experimental research designs.
Figure 2. Schematic of pre-experimental research designs.

When designing the experiment, note that there are many different approaches, each with their advantages and disadvantages. A full treatment of this topic is beyond the scope of this article. Suffice it to say that pre-experimental designs (Figure 2) are considered to generate weak evidence. But they are quick and easy and might be appropriate for pilot studies.

Schematic of a quasi-experimental research design.
Figure 3. Schematic of a quasi-experimental research design.

Quasi-experimental designs (Figure 3) generate a higher level of evidence. Such a design might be appropriate when you are stuck with collecting a convenience sample, rather than being able to use a full randomized assignment of study subjects.

The randomized controlled study design.
Figure 4. The randomized controlled study design.

The fully randomized design (Figure 4) generates the highest level of evidence. This is because if the sample size is large enough, the unknown and uncontrollable sources of bias are evenly distributed between the study groups. 

BASIC MEASUREMENT METHODS

If your research involves physical measurements, you need to be familiar with the devices considered to be the gold standards. In cardiopulmonary research, most measurements involve pressure volume, flow, and gas concentration. You need to know which devices are appropriate for static vs dynamic measurements of these variables. In addition, you need to understand issues related to systematic and random measurement errors and how these errors are managed through calibration and calibration verification. I recommend these two textbooks:

Principles and Practice of Intensive Care Monitoring 1st Edition by Martin J. Tobin MD.

  • This book is out of print, but if you can find a used copy or one in a library, it describes just about every kind of physiologic measurement used in clinical medicine.

Medical Instrumentation: Application and Design 4th Edition by John G. Webster.

  • This book is readily available and reasonably priced. It is a more technical book describing medical instrumentation and measurement principles. It is a standard textbook for biometrical engineers.

STATISTICS FOR THE UNINTERESTED

I know what you are thinking: I hate statistics. Look at the book Essential Biostatistics: A Nonmathematical Approach.15 It is a short, inexpensive paperback book that is easy to read. The author does a great job of explaining why we use statistics rather than getting bogged down explaining how we calculate them. After all, novice researchers usually seek the help of a professional statistician to do the heavy lifting.

My book, Handbook for Health Care Research,16 covers most of the statistical procedures you will encounter in medical research and gives examples of how to use a popular tactical software package called SigmaPlot. By the way, I strongly suggest that you consult a statistician early in your study design phase to avoid the disappointment of finding out later that your results are uninterpretable. For an in-depth treatment of the subject, I recommend How to Report Statistics in Medicine.17

Statistical bare essentials

Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data.
Figure 5. Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data. COPD = chronic obstructive pulmonary disease; PaCOs = partial pressure of carbon dioxide, artery; PS = pressure support; RDS = respiratory distress syndrome; SIMV = synchronized intermittent mandatory ventilation

To do research or even just to understand published research reports, you must have at least a minimal skill set. The necessary skills include understanding some basic terminology, if only to be able to communicate with a statistician consultant. Important terms include levels of measurement (nominal, ordinal, continuous), accuracy, precision, measures of central tendency (mean, median, mode), measures of variability (variance, standard deviation, coefficient of variation), and percentile. The first step in analyzing your results is usually to represent it graphically. That means you should be able to use a spreadsheet to make simple graphs (Figure 5).

Example flowchart for selecting the appropriate statistical test.
Figure 6. Example flowchart for selecting the appropriate statistical test. ANOVA = analysis of variance

You should also know the basics of inferential statistics (ie, hypothesis testing). For example, you need to know the difference between parametric and non-parametric tests. You should be able to explain correlation and regression and know when to use Chi-squared vs a Fisher exact test. You should know that when comparing two mean values, you typically use the Student’s t test (and know when to use paired vs unpaired versions of the test). When comparing more than 2 mean values, you use analysis of variance methods (ANOVA). You can teach yourself these concepts from a book,16 but even an introductory college level course on statistics will be immensely helpful. Most statistics textbooks provide some sort of map to guide your selection of the appropriate statistical test (Figure 6), and there are good articles in medical journals.

You can learn a lot simply by reading the Methods section of research articles. Authors will often describe the statistical tests used and why they were used. But be aware that a certain percentage of papers get published with the wrong statistics.18 

One of the underlying assumptions of most parametric statistical methods is that the data may be adequately described by a normal or Gaussian distribution. This assumption needs to be verified before selecting a statistical test. The common test for data normality is the Kolmogorov-Smirnov test. The following text from a methods section describes 2 very common procedures—the Student’s t test for comparing 2 mean values and the one-way ANOVA for comparing more than 2 mean values.19

“Normal distribution of data was verified using the Kolmogorov-Smirnov test. Body weights between groups were compared using one-way ANOVA for repeated measures to investigate temporal differences. At each time point, all data were analyzed using one-way ANOVA to compare PCV and VCV groups. Tukey’s post hoc analyses were performed when significant time effects were detected within groups, and Student’s t test was used to investigate differences between groups. Data were analyzed using commercial software and values were presented as mean ± SD. A P value < .05 was considered statistically significant.” 

 

 

Estimating sample size and power analysis

One very important consideration in any study is the required number of study subjects for meaningful statistical conclusions. In other words, how big should the sample size be? Sample size is important because it affects the feasibility of the study and the reliability of the conclusions in terms of statistical power. The necessary sample size depends on 2 basic factors. One factor is the variability of the data (often expressed as the standard deviation). The other factor is the effect size, meaning, for example, how big of a difference between mean values you want to detect. In general, the bigger the variability and the smaller the difference, the bigger the sample size required.

As the above equation shows, the effect size is expressed, in general, as a mean difference divided by a standard deviation. In the first case, the numerator represents the difference between the sample mean and the assumed population mean. In the denominator, SD is the standard deviation of the sample (used to estimate the standard deviation of the population). In the second case, the numerator represents the difference between the mean values of 2 samples and the denominator is the pooled standard deviation of the 2 samples.

In order to understand the issues involved with selecting sample size, we need to first understand the types of errors that can be made in any type of decision. Suppose our research goal is to make a decision about whether a new treatment results in a clinical difference (improvement). The results of our statistical test are dichotomous—we decide either yes there is a significant difference or no there isn’t. The truth, which we may never know, is that in reality, the difference exists or it doesn’t.

Types of errors in statistical decision making.
Figure 7. Types of errors in statistical decision making.

As Figure 7 shows, the result of our decision making is that there are 2 ways to be right and 2 ways to be wrong. If we decide there is a difference (eg, our statistical tests yields P ≤ .05) but in realty there is not a difference, then we make what is called a type I error. On the other hand, if we conclude that there is not a difference (ie, our statistical test yields P > .05) but in reality there is a difference that we did not detect, then we have made a type II error.

Probabilities associated with type I and type II errors.
Figure 8. Probabilities associated with type I and type II errors.

The associated math is shown in Figure 8. The probability of making a type I error is called alpha. By convention in medicine, we set our rejection criterion to alpha = 0.05. In other words, we would reject the null hypothesis (that there is no difference) anytime our statistical test yields a P value less than alpha. The probability of making a type II error is called beta. For historical reasons, the probability of not making a type II error is called the statistical power of the test and is equal to 1 minus beta. Power is affected by sample size: the larger the sample the larger the power. Most researchers, by convention, keep the sample size large enough to keep power above 0.80.

Nomogram for calculating power and sample size
Figure 9. Nomogram for calculating power and sample size.

Figure 9 is a nomogram that brings all these ideas together. The red line shows that for your study, given the desired effect size (0.8), if you collected samples from the 30 patients you planned on then the power would be unacceptable at 0.60, indicating a high probability of a false negative decision if the P value comes out greater than .50. The solution is to increase the sample size to about 50 (or more), as indicated by the blue line. From this nomogram we can generalize to say that when you want to detect a small effect with data that have high variability, you need a large sample size to provide acceptable power.

The text below is an example of a power analysis presented in the methods section of a published study.20 Note that the authors give their reasoning for the sample size they selected. This kind of explanation may inform your study design. But what if you don’t know the variability of the data you want to collect? In that case, you need to collect some pilot data and calculate from that an appropriate sample size for a subsequent study.

A prospective power calculation indicated that a sample size of 25 per group was required to achieve 80% power based on an effect size of probability of 0.24 that an observation in the PRVCa group is less than an observation in the ASV group using the Mann-Whitney tests, an alpha of 0.05 (two-tailed) and a 20% dropout.

JUDGING FEASIBILITY

Once you have a draft of your study design, including the estimated sample size, it is time to judge the overall feasibility of the study before committing to it.

Factors to consider when judging the feasibility of a new study
Table 1 shows some of the most important factors in judging feasibility. The first question is whether the outcome will be worth the resources needed to complete the study, implying that you must define costs and benefits. Second, assure yourself that you can both define and measure the outcome variables of interest, which can be a challenge in psychological studies and even in quality improvement projects. Next consider the time constraints, which are affected mainly by the sample size and the time needed to observe all the individuals in that sample. Naturally, if you are studying a rare disorder, the time needed to collect even a modest sample size may make the project impractical.

Every study has associated costs. Those costs and the sources of funding must be identified. Don’t forget costs for consultants, particularly if you need statistical consultation.

Finally, consider your level of experience. If you are contemplating your first study, a human clinical trial might not be the best choice, given the complexity of such a project. Studies such as a meta-analysis or mathematical simulation require special training beyond basic research procedures, and should be avoided.

References
  1. Tobin MJ. Mentoring: seven roles and some specifics. Am J Respir Crit Care Med 2004; 170:114–117.
  2. Chatburn RL. Advancing beyond the average: the importance of mentoring in professional achievement. Respir Care 2004; 49:304–308.
  3. Beveridge WIB. The Art of Scientific Investigation. New York, NY: WW Norton & Company; 1950.
  4. Chatburn RL, Mireles-Cabodevila E, Sasidhar M. Tidal volume measurement error in pressure control modes of mechanical ventilation: a model study. Comput Biol Med 2016; 75:235–242.
  5. Mireles-Cabodevila E, Chatburn RL. Work of breathing in adaptive pressure control continuous mandatory ventilation. Respir Care 2009; 54:1467–1472.
  6. Chatburn RL, Ford RM. Procedure to normalize data for benchmarking. Respir Care 2006; 51:145–157.
  7. Bou-Khalil P, Zeineldine S, Chatburn R, et al. Prediction of inspired oxygen fraction for targeted arterial oxygen tension following open heart surgery in non-smoking and smoking patients. J Clin Monit Comput 2016. https://doi.org/10.1007/s10877-016-9941-6.
  8. Mireles-Cabodevila E, Diaz-Guzman E, Arroliga AC, Chatburn RL. Human versus computer controlled selection of ventilator settings: an evaluation of adaptive support ventilation and mid-frequency ventilation. Crit Care Res Pract 2012; 2012:204314.
  9. Chatburn RL. How to find the best evidence. Respir Care 2009; 54:1360–1365.
  10. Durbin CG Jr. How to read a scientific research paper. Respir Care 2009; 54:1366–1371.
  11. Pierson DJ. How to read a case report (or teaching case of the month). Respir Care 2009; 54:1372–1378.
  12. Callcut RA, Branson RD. How to read a review paper. Respir Care 2009; 54:1379–1385.
  13. Eresuma E, Lake E. How do I find the evidence? Find your librarian—stat! Orthop Nurs 2016; 35:421–423.
  14. Janke R, Rush KL. The academic librarian as co-investigator on an interprofessional primary research team: a case study. Health Info Libr J 2014; 31:116–122.
  15. Motulsky H. Essential Biostatistics: A Nonmathematical Approach. New York, NY: Oxford University Press; 2016.
  16. Chatburn RL. Handbook for Health Care Research. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2011.
  17. Lang TA, Secic M. How to Report Statistics in Medicine. 2nd ed. Philadelphia, PA: American College of Physicians; 2006.
  18. Prescott RJ, Civil I. Lies, damn lies and statistics: errors and omission in papers submitted to INJURY 2010–2012. Injury 2013; 44:6–11.
  19. Fantoni DT, Ida KK, Lopes TF, Otsuki DA, Auler JO Jr, Ambrosio AM. A comparison of the cardiopulmonary effects of pressure controlled ventilation and volume controlled ventilation in healthy anesthetized dogs. J Vet Emerg Crit Care (San Antonio) 2016; 26:524–530.
  20. Gruber PC, Gomersall CD, Leung P, et al. Randomized controlled trial comparing adaptive-support ventilation with pressure-regulated volume-controlled ventilation with automode in weaning patients after cardiac surgery. Anesthesiology 2008; 109:81–87.
Article PDF
Author and Disclosure Information

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Respiratory Institute; Director Simulation Fellowship, Education Institute; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Correspondence: Robert L. Chatburn, MHHS, RRT-NPS, FAARC, Clinical Research Manager, Respiratory Institute, M56, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; chatbur@ccf.org

This article is based on Mr. Chatburn’s presentation at the “Biostatistics and Epidemiology” lecture series created by Aanchal Kapoor, MD, Critical Care Medicine, Cleveland Clinic. Mr. Chatburn presented his lecture on September 6, 2016, at Cleveland Clinic.

Mr. Chatburn reported no financial interests or relationships that pose a potential conflict of interest with this article.

Publications
Page Number
e10-e19
Legacy Keywords
study design, statistics, hypothesis testing, sample size, power, Robert Chatburn
Author and Disclosure Information

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Respiratory Institute; Director Simulation Fellowship, Education Institute; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Correspondence: Robert L. Chatburn, MHHS, RRT-NPS, FAARC, Clinical Research Manager, Respiratory Institute, M56, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; chatbur@ccf.org

This article is based on Mr. Chatburn’s presentation at the “Biostatistics and Epidemiology” lecture series created by Aanchal Kapoor, MD, Critical Care Medicine, Cleveland Clinic. Mr. Chatburn presented his lecture on September 6, 2016, at Cleveland Clinic.

Mr. Chatburn reported no financial interests or relationships that pose a potential conflict of interest with this article.

Author and Disclosure Information

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Respiratory Institute; Director Simulation Fellowship, Education Institute; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

Correspondence: Robert L. Chatburn, MHHS, RRT-NPS, FAARC, Clinical Research Manager, Respiratory Institute, M56, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; chatbur@ccf.org

This article is based on Mr. Chatburn’s presentation at the “Biostatistics and Epidemiology” lecture series created by Aanchal Kapoor, MD, Critical Care Medicine, Cleveland Clinic. Mr. Chatburn presented his lecture on September 6, 2016, at Cleveland Clinic.

Mr. Chatburn reported no financial interests or relationships that pose a potential conflict of interest with this article.

Article PDF
Article PDF
Related Articles
From the “Biostatistics and Epidemiology Lecture Series, Part 1”
From the “Biostatistics and Epidemiology Lecture Series, Part 1”

INTRODUCTION

Basic research skills are not acquired from medical school but from a mentor.1,2 A mentor with experience in study design and technical writing can make a real difference in your career. Most good mentors have more ideas for studies than they have time for research, so they are willing to share and guide your course. Your daily clinical experience provides a wealth of ideas in the form of “why do we do it this way” or “what is the evidence for” or “how can we improve outcomes or cut cost?” Of course, just about every study you read in a medical journal has suggestions for further research in the discussion section. Finally, keep in mind that the creation of study ideas and in particular, hypotheses, is a mysterious process, as this quote indicates: “It is not possible, deliberately, to create ideas or to control their creation. What we can do deliberately is to prepare our minds.” 3 Remember that chance favors the prepared mind.

DEVELOPING THE STUDY IDEA

Often, the most difficult task for someone new to research is developing a practical study idea. This section will explain a detailed process for creating a formal research protocol. We will focus on two common sticking points: (1) finding a good idea, and (2) developing a good idea into a problem statement.

Novice researchers with little experience, no mentors, and short time frames are encouraged not to take on a clinical human study as the principle investigator. Instead, device evaluations are a low-cost, time-efficient alternative. Human studies in the form of a survey are also possible and are often exempt from full Institutional Review Board (IRB) review. Many human-like conditions can be simulated, as was done, for example, in the study of patient-ventilator synchrony.4,5 And if you have the aptitude, whole studies can be based on mathematical models and predictions, particularly with the vast array of computer tools now available.6,7 And don’t forget studies based on surveys.8

A structured approach

A structured approach for developing a formal research protocol.
Figure 1. A structured approach for developing a formal research protocol.

A formal research protocol is required for any human research. However, it is also recommended for all but the simplest investigations. Most of the new researchers I have mentored take a rather lax approach to developing the protocol, and most IRBs are more interested in protecting human rights than validating the study design. As a result, much time is wasted and sometimes an entire study has to be abandoned due to poor planning. Figure 1 illustrates a structured approach that helps to ensure success. It shows a 3-step, iterative process.

The first step is a process of expanding the scope of the project, primarily through literature review. Along the way you learn (or invent) appropriate terminology and become familiar with the current state of the research art on a broad topic. For example, let’s suppose you were interested in the factors that affect the duration of mechanical ventilation. The literature review might include topics such as weaning and patient-ventilator synchrony as well as ventilator-associated pneumonia. During this process, you might discover that the topic of synchrony is currently generating a lot of interest in the literature and generating a lot of questions or confusion. You then focus on expanding your knowledge in this area.

In the second step, you might develop a theoretical framework for understanding patient-ventilator synchrony that could include a mathematical model and, perhaps, an idea to include simulation to study the problem.

In the third step, you need to narrow the scope of the study to a manageable level that includes identifying measurable outcome variables, creating testable hypotheses, considering experimental designs, and evaluating the overall feasibility of the study. At this point, you may discover that you cannot measure the specific outcome variables indicated by your theoretical framework. In that case, you need to create a new framework for supporting your research. Alternatively, you may find that it is not possible to conduct the study you envision given your resources. In that case, it is back to step 1.

Eventually, this process will result in a well-planned research protocol that is ready for review. Keep in mind that many times a protocol needs to be refined after some initial experiments are conducted. For human studies, any changes to the protocol must be approved by the IRB.

The problem statement rubric

The most common problem I have seen novices struggle with is creating a meaningful problem statement and hypothesis. This is crucial because the problem statement sets the stage for the methods, the methods yield the results, and the results are analyzed in light of the original problem statement and hypotheses. To get past any writer’s block, I recommend that you start by just describing what you see happening and why you think it is important. For example, you might say, “Patients with acute lung injury often seem to be fighting the ventilator.” This is important because patient-ventilator asynchrony may lead to increased sedation levels and prolonged intensive care unit stays. Now you can more easily envision a specific purpose and testable hypothesis. For example, you could state that the purpose of this study is to determine the baseline rates of different kinds of patient-ventilator synchrony problems. The hypothesis is that the rate of dyssynchrony is correlated with duration of mechanical ventilation.

Here is an actual example of how a problem statement evolved from a vague notion to a testable hypothesis.

Original: The purpose of this study is to determine whether measures of ineffective cough in patients with stroke recently liberated from mechanical ventilation correlate with risk of extubation failure and reintubation.

Final: The purpose of this study is to test the hypothesis that use of CoughAssist device in the immediate post-extubation period by stroke patients reduces the rate of extubation failure and pneumonia.

The original statement is a run-on sentence that is vague and hard to follow. Once the actual treatment and outcome measures are in focus, then a clear hypothesis statement can be made. Notice that the hypothesis should be clear enough that the reader can anticipate the actual experimental measures and procedures to be described in the methods section of the protocol.

Here is another example:

Original: The purpose of this study is to evaluate a device that allows continuous electronic cuff pressure control.

Final: The purpose of this study is to test the hypothesis that the Pressure Eyes electronic cuff monitor will maintain constant endotracheal tube cuff pressures better than manual cuff inflation during mechanical ventilation.

The problem with the original statement is that “to evaluate” is vague. The final statement makes the outcome variable explicit and suggests what the experimental procedure will be.

This is a final example:

Original: Following cardiac/respiratory arrest, many patients are profoundly acidotic. Ventilator settings based on initial arterial blood gases may result in inappropriate hyperventilation when follow-up is delayed. The purpose of this study is to establish the frequency of this occurrence at a large academic institution and the feasibility of a quality improvement project.

Final: The primary purpose of this study is to evaluate the frequency of hyperventilation occurring post-arrest during the first 24 hours. A secondary purpose is to determine if this hyperventilation is associated with an initial diagnosis of acidosis.

Note that the original statement follows the rubric of telling us what is observed and why it is important. However, the actual problem statement derived from the observation is vague: what is “this occurrence” and is the study really to establish any kind of feasibility? The purpose is simply to evaluate the frequency of hyperventilation and determine if the condition is associated with acidosis.

 

 

EXAMPLES OF RESEARCH PROJECTS BY FELLOWS

The following are examples of well-written statements of study purpose from actual studies conducted by our fellows.

Device evaluation

Defining “Flow Starvation” in volume control mechanical ventilation.

  • The purpose of this study is to evaluate the relationship between the patient and ventilator inspiratory work of breathing to define the term “Flow Starvation.”

Auto-positive end expiratory pressure (auto-PEEP) during airway pressure release ventilation varies with the ventilator model.

  • The purpose of this study was to compare auto-PEEP levels, peak expiratory flows, and flow decay profiles among 4 common intensive care ventilators.

Patient study

Diaphragmatic electrical activity and extubation outcomes in newborn infants: an observational study.

  • The purpose of this study is to describe the electrical activity of the diaphragm before, during, and after extubation in a mixed-age cohort of preterm infants.

Comparison of predicted and measured carbon dioxide production for monitoring dead space fraction during mechanical ventilation.

  • The purpose of this pilot study was to compare dead space with tidal volume ratios calculated from estimated and measured values for carbon dioxide production.

Practice evaluation

Incidence of asynchronies during invasive mechanical ventilation in a medical intensive care unit.

  • The purpose of this study is to conduct a pilot investigation to determine the baseline incidence of various forms of patient-ventilator dyssynchrony during invasive mechanical ventilation.

Simulation training results in improved knowledge about intubation policies and procedures.

  • The purpose of this study was to develop and test a simulation-based rapid-sequence intubation curriculum for fellows in pulmonary and critical care training.

HOW TO SEARCH THE LITERATURE

After creating a problem statement, the next step in planning research is to search the literature. The 10th issue of Respiratory Care journal in 2009 was devoted to research. Here are the articles in that issue related to the literature search:

  • How to find the best evidence (search internet)9
  • How to read a scientific research paper10
  • How to read a case report (or teaching case of the month)11
  • How to read a review paper.12

I recommend that you read these papers.

Literature search resources

My best advice is to befriend your local librarian.13 These people seldom get the recognition they deserve as experts at finding information and even as co-investigators.14 In addition to personal help, some libraries offer training sessions on various useful skills.

PubMed

The Internet resource I use most often is PubMed (www.ncbi.nlm.nih.gov/pubmed). It offers free access to MEDLINE, which is the National Library of Medicine’s database of citations and abstracts in the fields of medicine, nursing, dentistry, veterinary medicine, health care systems, and preclinical sciences. There are links to full-text articles and other resources. The website provides a clinical queries search filters page as well as a special queries page. Using a feature called “My NCBI,” you can have automatic e-mailing of search updates and save records and filters for search results. Access the PubMed Quick Start Guide for frequently asked questions and tutorials.

SearchMedica.com

The SearchMedica website (www.searchmedica.co.uk) is free and intended for medical professionals. It provides answers for clinical questions. Searches return articles, abstracts, and recommended medical websites.

Synthetic databases

There is a class of websites called synthetic databases, which are essentially prefiltered records for particular topics. However, these sites are usually subscription-based, and the cost is relatively high. You should check with your medical library to get access. Their advantage is that often they provide the best evidence without extensive searches of standard, bibliographic databases. Examples include the Cochrane Database of Systematic Reviews (www.cochrane.org/evidence), the National Guideline Clearinghouse (www.guideline.gov), and UpToDate (www.uptodate.com). UpToDate claims to be the largest clinical community in the world dedicated to synthesized knowledge for clinicians and patients. It features the work of more than 6,000 expert clinician authors/reviewers on more than 10,000 topics in 23 medical specialties. The site offers graded recommendations based on the best medical evidence.

Portals

Portals are web pages that act as a starting point for using the web or web-based services. One popular example is ClinicalKey (www.clinicalkey.com/info), formerly called MD Consult, which offers books, journals, patient education materials, and images. Another popular portal is Ovid (ovid.com), offering books, journals, evidence-based medicine databases, and CINAHL (Cumulative Index to Nursing and Allied Health Literature).

Electronic journals

Many medical journals now have online databases of current and archived issues. Such sites may require membership to access the databases, so again, check with your medical library. Popular examples in pulmonary and critical care medicine include the following:

Electronic books

Amazon.com is a great database search engine for books on specific topics. It even finds out-of-print books. And you don’t have to buy the books, because now you can rent them. Sometimes, I find what I wanted by using the “Look Inside” feature for some books. Note that you can look for books at PubMed. Just change the search box from PubMed to Books on the PubMed home page. Of course, Google also has a book search feature. A great (subscription) resource for medical and technical books is Safari (https://www.safaribooksonline.com). Once again, your library may have a subscription.

General Internet resources

You probably already know about Google Scholar (scholar.google.com) and Wikipedia.com. Because of its open source nature, you should use Wikipedia with caution. However, I have found it to be a very good first step in finding technical information, particularly about mathematics, physics, and statistics.

 

 

Using reference management software

One of the most important things you can do to make your research life easier is to use some sort of reference management software. As described in Wikipedia, “Reference management software, citation management software or personal bibliographic management software is software for scholars and authors to use for recording and using bibliographic citations (references). Once a citation has been recorded, it can be used time and again in generating bibliographies, such as lists of references in scholarly books, articles, and essays.” I was late in adopting this technology, but now I am a firm believer. Most Internet reference sources offer the ability to download citations to your reference management software. Downloading automatically places the citation into a searchable database on your computer with backup to the Internet. In addition, you can get the reference manager software to find a PDF version of the manuscript and store it with the citation on your computer (and/or in the Cloud) automatically.

But the most powerful feature of such software is its ability to add or subtract and rearrange the order of references in your manuscripts as you are writing, using seamless integration with Microsoft Word. The references can be automatically formatted using just about any journal’s style. This is a great time saver for resubmitting manuscripts to different journals. If you are still numbering references by hand (God forbid) or even using the Insert Endnote feature in Word (deficient when using multiple occurrences of the same reference), your life will be much easier if you take the time to start using reference management software.

The most popular commercial software is probably EndNote (endnote.com). A really good free software system with about the same functionality as Zotero (zotero.com). Search for “comparison of reference management software” in Wikipedia. You can find tutorials on software packages in YouTube.

STUDY DESIGN

Schematic of pre-experimental research designs.
Figure 2. Schematic of pre-experimental research designs.

When designing the experiment, note that there are many different approaches, each with their advantages and disadvantages. A full treatment of this topic is beyond the scope of this article. Suffice it to say that pre-experimental designs (Figure 2) are considered to generate weak evidence. But they are quick and easy and might be appropriate for pilot studies.

Schematic of a quasi-experimental research design.
Figure 3. Schematic of a quasi-experimental research design.

Quasi-experimental designs (Figure 3) generate a higher level of evidence. Such a design might be appropriate when you are stuck with collecting a convenience sample, rather than being able to use a full randomized assignment of study subjects.

The randomized controlled study design.
Figure 4. The randomized controlled study design.

The fully randomized design (Figure 4) generates the highest level of evidence. This is because if the sample size is large enough, the unknown and uncontrollable sources of bias are evenly distributed between the study groups. 

BASIC MEASUREMENT METHODS

If your research involves physical measurements, you need to be familiar with the devices considered to be the gold standards. In cardiopulmonary research, most measurements involve pressure volume, flow, and gas concentration. You need to know which devices are appropriate for static vs dynamic measurements of these variables. In addition, you need to understand issues related to systematic and random measurement errors and how these errors are managed through calibration and calibration verification. I recommend these two textbooks:

Principles and Practice of Intensive Care Monitoring 1st Edition by Martin J. Tobin MD.

  • This book is out of print, but if you can find a used copy or one in a library, it describes just about every kind of physiologic measurement used in clinical medicine.

Medical Instrumentation: Application and Design 4th Edition by John G. Webster.

  • This book is readily available and reasonably priced. It is a more technical book describing medical instrumentation and measurement principles. It is a standard textbook for biometrical engineers.

STATISTICS FOR THE UNINTERESTED

I know what you are thinking: I hate statistics. Look at the book Essential Biostatistics: A Nonmathematical Approach.15 It is a short, inexpensive paperback book that is easy to read. The author does a great job of explaining why we use statistics rather than getting bogged down explaining how we calculate them. After all, novice researchers usually seek the help of a professional statistician to do the heavy lifting.

My book, Handbook for Health Care Research,16 covers most of the statistical procedures you will encounter in medical research and gives examples of how to use a popular tactical software package called SigmaPlot. By the way, I strongly suggest that you consult a statistician early in your study design phase to avoid the disappointment of finding out later that your results are uninterpretable. For an in-depth treatment of the subject, I recommend How to Report Statistics in Medicine.17

Statistical bare essentials

Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data.
Figure 5. Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data. COPD = chronic obstructive pulmonary disease; PaCOs = partial pressure of carbon dioxide, artery; PS = pressure support; RDS = respiratory distress syndrome; SIMV = synchronized intermittent mandatory ventilation

To do research or even just to understand published research reports, you must have at least a minimal skill set. The necessary skills include understanding some basic terminology, if only to be able to communicate with a statistician consultant. Important terms include levels of measurement (nominal, ordinal, continuous), accuracy, precision, measures of central tendency (mean, median, mode), measures of variability (variance, standard deviation, coefficient of variation), and percentile. The first step in analyzing your results is usually to represent it graphically. That means you should be able to use a spreadsheet to make simple graphs (Figure 5).

Example flowchart for selecting the appropriate statistical test.
Figure 6. Example flowchart for selecting the appropriate statistical test. ANOVA = analysis of variance

You should also know the basics of inferential statistics (ie, hypothesis testing). For example, you need to know the difference between parametric and non-parametric tests. You should be able to explain correlation and regression and know when to use Chi-squared vs a Fisher exact test. You should know that when comparing two mean values, you typically use the Student’s t test (and know when to use paired vs unpaired versions of the test). When comparing more than 2 mean values, you use analysis of variance methods (ANOVA). You can teach yourself these concepts from a book,16 but even an introductory college level course on statistics will be immensely helpful. Most statistics textbooks provide some sort of map to guide your selection of the appropriate statistical test (Figure 6), and there are good articles in medical journals.

You can learn a lot simply by reading the Methods section of research articles. Authors will often describe the statistical tests used and why they were used. But be aware that a certain percentage of papers get published with the wrong statistics.18 

One of the underlying assumptions of most parametric statistical methods is that the data may be adequately described by a normal or Gaussian distribution. This assumption needs to be verified before selecting a statistical test. The common test for data normality is the Kolmogorov-Smirnov test. The following text from a methods section describes 2 very common procedures—the Student’s t test for comparing 2 mean values and the one-way ANOVA for comparing more than 2 mean values.19

“Normal distribution of data was verified using the Kolmogorov-Smirnov test. Body weights between groups were compared using one-way ANOVA for repeated measures to investigate temporal differences. At each time point, all data were analyzed using one-way ANOVA to compare PCV and VCV groups. Tukey’s post hoc analyses were performed when significant time effects were detected within groups, and Student’s t test was used to investigate differences between groups. Data were analyzed using commercial software and values were presented as mean ± SD. A P value < .05 was considered statistically significant.” 

 

 

Estimating sample size and power analysis

One very important consideration in any study is the required number of study subjects for meaningful statistical conclusions. In other words, how big should the sample size be? Sample size is important because it affects the feasibility of the study and the reliability of the conclusions in terms of statistical power. The necessary sample size depends on 2 basic factors. One factor is the variability of the data (often expressed as the standard deviation). The other factor is the effect size, meaning, for example, how big of a difference between mean values you want to detect. In general, the bigger the variability and the smaller the difference, the bigger the sample size required.

As the above equation shows, the effect size is expressed, in general, as a mean difference divided by a standard deviation. In the first case, the numerator represents the difference between the sample mean and the assumed population mean. In the denominator, SD is the standard deviation of the sample (used to estimate the standard deviation of the population). In the second case, the numerator represents the difference between the mean values of 2 samples and the denominator is the pooled standard deviation of the 2 samples.

In order to understand the issues involved with selecting sample size, we need to first understand the types of errors that can be made in any type of decision. Suppose our research goal is to make a decision about whether a new treatment results in a clinical difference (improvement). The results of our statistical test are dichotomous—we decide either yes there is a significant difference or no there isn’t. The truth, which we may never know, is that in reality, the difference exists or it doesn’t.

Types of errors in statistical decision making.
Figure 7. Types of errors in statistical decision making.

As Figure 7 shows, the result of our decision making is that there are 2 ways to be right and 2 ways to be wrong. If we decide there is a difference (eg, our statistical tests yields P ≤ .05) but in realty there is not a difference, then we make what is called a type I error. On the other hand, if we conclude that there is not a difference (ie, our statistical test yields P > .05) but in reality there is a difference that we did not detect, then we have made a type II error.

Probabilities associated with type I and type II errors.
Figure 8. Probabilities associated with type I and type II errors.

The associated math is shown in Figure 8. The probability of making a type I error is called alpha. By convention in medicine, we set our rejection criterion to alpha = 0.05. In other words, we would reject the null hypothesis (that there is no difference) anytime our statistical test yields a P value less than alpha. The probability of making a type II error is called beta. For historical reasons, the probability of not making a type II error is called the statistical power of the test and is equal to 1 minus beta. Power is affected by sample size: the larger the sample the larger the power. Most researchers, by convention, keep the sample size large enough to keep power above 0.80.

Nomogram for calculating power and sample size
Figure 9. Nomogram for calculating power and sample size.

Figure 9 is a nomogram that brings all these ideas together. The red line shows that for your study, given the desired effect size (0.8), if you collected samples from the 30 patients you planned on then the power would be unacceptable at 0.60, indicating a high probability of a false negative decision if the P value comes out greater than .50. The solution is to increase the sample size to about 50 (or more), as indicated by the blue line. From this nomogram we can generalize to say that when you want to detect a small effect with data that have high variability, you need a large sample size to provide acceptable power.

The text below is an example of a power analysis presented in the methods section of a published study.20 Note that the authors give their reasoning for the sample size they selected. This kind of explanation may inform your study design. But what if you don’t know the variability of the data you want to collect? In that case, you need to collect some pilot data and calculate from that an appropriate sample size for a subsequent study.

A prospective power calculation indicated that a sample size of 25 per group was required to achieve 80% power based on an effect size of probability of 0.24 that an observation in the PRVCa group is less than an observation in the ASV group using the Mann-Whitney tests, an alpha of 0.05 (two-tailed) and a 20% dropout.

JUDGING FEASIBILITY

Once you have a draft of your study design, including the estimated sample size, it is time to judge the overall feasibility of the study before committing to it.

Factors to consider when judging the feasibility of a new study
Table 1 shows some of the most important factors in judging feasibility. The first question is whether the outcome will be worth the resources needed to complete the study, implying that you must define costs and benefits. Second, assure yourself that you can both define and measure the outcome variables of interest, which can be a challenge in psychological studies and even in quality improvement projects. Next consider the time constraints, which are affected mainly by the sample size and the time needed to observe all the individuals in that sample. Naturally, if you are studying a rare disorder, the time needed to collect even a modest sample size may make the project impractical.

Every study has associated costs. Those costs and the sources of funding must be identified. Don’t forget costs for consultants, particularly if you need statistical consultation.

Finally, consider your level of experience. If you are contemplating your first study, a human clinical trial might not be the best choice, given the complexity of such a project. Studies such as a meta-analysis or mathematical simulation require special training beyond basic research procedures, and should be avoided.

INTRODUCTION

Basic research skills are not acquired from medical school but from a mentor.1,2 A mentor with experience in study design and technical writing can make a real difference in your career. Most good mentors have more ideas for studies than they have time for research, so they are willing to share and guide your course. Your daily clinical experience provides a wealth of ideas in the form of “why do we do it this way” or “what is the evidence for” or “how can we improve outcomes or cut cost?” Of course, just about every study you read in a medical journal has suggestions for further research in the discussion section. Finally, keep in mind that the creation of study ideas and in particular, hypotheses, is a mysterious process, as this quote indicates: “It is not possible, deliberately, to create ideas or to control their creation. What we can do deliberately is to prepare our minds.” 3 Remember that chance favors the prepared mind.

DEVELOPING THE STUDY IDEA

Often, the most difficult task for someone new to research is developing a practical study idea. This section will explain a detailed process for creating a formal research protocol. We will focus on two common sticking points: (1) finding a good idea, and (2) developing a good idea into a problem statement.

Novice researchers with little experience, no mentors, and short time frames are encouraged not to take on a clinical human study as the principle investigator. Instead, device evaluations are a low-cost, time-efficient alternative. Human studies in the form of a survey are also possible and are often exempt from full Institutional Review Board (IRB) review. Many human-like conditions can be simulated, as was done, for example, in the study of patient-ventilator synchrony.4,5 And if you have the aptitude, whole studies can be based on mathematical models and predictions, particularly with the vast array of computer tools now available.6,7 And don’t forget studies based on surveys.8

A structured approach

A structured approach for developing a formal research protocol.
Figure 1. A structured approach for developing a formal research protocol.

A formal research protocol is required for any human research. However, it is also recommended for all but the simplest investigations. Most of the new researchers I have mentored take a rather lax approach to developing the protocol, and most IRBs are more interested in protecting human rights than validating the study design. As a result, much time is wasted and sometimes an entire study has to be abandoned due to poor planning. Figure 1 illustrates a structured approach that helps to ensure success. It shows a 3-step, iterative process.

The first step is a process of expanding the scope of the project, primarily through literature review. Along the way you learn (or invent) appropriate terminology and become familiar with the current state of the research art on a broad topic. For example, let’s suppose you were interested in the factors that affect the duration of mechanical ventilation. The literature review might include topics such as weaning and patient-ventilator synchrony as well as ventilator-associated pneumonia. During this process, you might discover that the topic of synchrony is currently generating a lot of interest in the literature and generating a lot of questions or confusion. You then focus on expanding your knowledge in this area.

In the second step, you might develop a theoretical framework for understanding patient-ventilator synchrony that could include a mathematical model and, perhaps, an idea to include simulation to study the problem.

In the third step, you need to narrow the scope of the study to a manageable level that includes identifying measurable outcome variables, creating testable hypotheses, considering experimental designs, and evaluating the overall feasibility of the study. At this point, you may discover that you cannot measure the specific outcome variables indicated by your theoretical framework. In that case, you need to create a new framework for supporting your research. Alternatively, you may find that it is not possible to conduct the study you envision given your resources. In that case, it is back to step 1.

Eventually, this process will result in a well-planned research protocol that is ready for review. Keep in mind that many times a protocol needs to be refined after some initial experiments are conducted. For human studies, any changes to the protocol must be approved by the IRB.

The problem statement rubric

The most common problem I have seen novices struggle with is creating a meaningful problem statement and hypothesis. This is crucial because the problem statement sets the stage for the methods, the methods yield the results, and the results are analyzed in light of the original problem statement and hypotheses. To get past any writer’s block, I recommend that you start by just describing what you see happening and why you think it is important. For example, you might say, “Patients with acute lung injury often seem to be fighting the ventilator.” This is important because patient-ventilator asynchrony may lead to increased sedation levels and prolonged intensive care unit stays. Now you can more easily envision a specific purpose and testable hypothesis. For example, you could state that the purpose of this study is to determine the baseline rates of different kinds of patient-ventilator synchrony problems. The hypothesis is that the rate of dyssynchrony is correlated with duration of mechanical ventilation.

Here is an actual example of how a problem statement evolved from a vague notion to a testable hypothesis.

Original: The purpose of this study is to determine whether measures of ineffective cough in patients with stroke recently liberated from mechanical ventilation correlate with risk of extubation failure and reintubation.

Final: The purpose of this study is to test the hypothesis that use of CoughAssist device in the immediate post-extubation period by stroke patients reduces the rate of extubation failure and pneumonia.

The original statement is a run-on sentence that is vague and hard to follow. Once the actual treatment and outcome measures are in focus, then a clear hypothesis statement can be made. Notice that the hypothesis should be clear enough that the reader can anticipate the actual experimental measures and procedures to be described in the methods section of the protocol.

Here is another example:

Original: The purpose of this study is to evaluate a device that allows continuous electronic cuff pressure control.

Final: The purpose of this study is to test the hypothesis that the Pressure Eyes electronic cuff monitor will maintain constant endotracheal tube cuff pressures better than manual cuff inflation during mechanical ventilation.

The problem with the original statement is that “to evaluate” is vague. The final statement makes the outcome variable explicit and suggests what the experimental procedure will be.

This is a final example:

Original: Following cardiac/respiratory arrest, many patients are profoundly acidotic. Ventilator settings based on initial arterial blood gases may result in inappropriate hyperventilation when follow-up is delayed. The purpose of this study is to establish the frequency of this occurrence at a large academic institution and the feasibility of a quality improvement project.

Final: The primary purpose of this study is to evaluate the frequency of hyperventilation occurring post-arrest during the first 24 hours. A secondary purpose is to determine if this hyperventilation is associated with an initial diagnosis of acidosis.

Note that the original statement follows the rubric of telling us what is observed and why it is important. However, the actual problem statement derived from the observation is vague: what is “this occurrence” and is the study really to establish any kind of feasibility? The purpose is simply to evaluate the frequency of hyperventilation and determine if the condition is associated with acidosis.

 

 

EXAMPLES OF RESEARCH PROJECTS BY FELLOWS

The following are examples of well-written statements of study purpose from actual studies conducted by our fellows.

Device evaluation

Defining “Flow Starvation” in volume control mechanical ventilation.

  • The purpose of this study is to evaluate the relationship between the patient and ventilator inspiratory work of breathing to define the term “Flow Starvation.”

Auto-positive end expiratory pressure (auto-PEEP) during airway pressure release ventilation varies with the ventilator model.

  • The purpose of this study was to compare auto-PEEP levels, peak expiratory flows, and flow decay profiles among 4 common intensive care ventilators.

Patient study

Diaphragmatic electrical activity and extubation outcomes in newborn infants: an observational study.

  • The purpose of this study is to describe the electrical activity of the diaphragm before, during, and after extubation in a mixed-age cohort of preterm infants.

Comparison of predicted and measured carbon dioxide production for monitoring dead space fraction during mechanical ventilation.

  • The purpose of this pilot study was to compare dead space with tidal volume ratios calculated from estimated and measured values for carbon dioxide production.

Practice evaluation

Incidence of asynchronies during invasive mechanical ventilation in a medical intensive care unit.

  • The purpose of this study is to conduct a pilot investigation to determine the baseline incidence of various forms of patient-ventilator dyssynchrony during invasive mechanical ventilation.

Simulation training results in improved knowledge about intubation policies and procedures.

  • The purpose of this study was to develop and test a simulation-based rapid-sequence intubation curriculum for fellows in pulmonary and critical care training.

HOW TO SEARCH THE LITERATURE

After creating a problem statement, the next step in planning research is to search the literature. The 10th issue of Respiratory Care journal in 2009 was devoted to research. Here are the articles in that issue related to the literature search:

  • How to find the best evidence (search internet)9
  • How to read a scientific research paper10
  • How to read a case report (or teaching case of the month)11
  • How to read a review paper.12

I recommend that you read these papers.

Literature search resources

My best advice is to befriend your local librarian.13 These people seldom get the recognition they deserve as experts at finding information and even as co-investigators.14 In addition to personal help, some libraries offer training sessions on various useful skills.

PubMed

The Internet resource I use most often is PubMed (www.ncbi.nlm.nih.gov/pubmed). It offers free access to MEDLINE, which is the National Library of Medicine’s database of citations and abstracts in the fields of medicine, nursing, dentistry, veterinary medicine, health care systems, and preclinical sciences. There are links to full-text articles and other resources. The website provides a clinical queries search filters page as well as a special queries page. Using a feature called “My NCBI,” you can have automatic e-mailing of search updates and save records and filters for search results. Access the PubMed Quick Start Guide for frequently asked questions and tutorials.

SearchMedica.com

The SearchMedica website (www.searchmedica.co.uk) is free and intended for medical professionals. It provides answers for clinical questions. Searches return articles, abstracts, and recommended medical websites.

Synthetic databases

There is a class of websites called synthetic databases, which are essentially prefiltered records for particular topics. However, these sites are usually subscription-based, and the cost is relatively high. You should check with your medical library to get access. Their advantage is that often they provide the best evidence without extensive searches of standard, bibliographic databases. Examples include the Cochrane Database of Systematic Reviews (www.cochrane.org/evidence), the National Guideline Clearinghouse (www.guideline.gov), and UpToDate (www.uptodate.com). UpToDate claims to be the largest clinical community in the world dedicated to synthesized knowledge for clinicians and patients. It features the work of more than 6,000 expert clinician authors/reviewers on more than 10,000 topics in 23 medical specialties. The site offers graded recommendations based on the best medical evidence.

Portals

Portals are web pages that act as a starting point for using the web or web-based services. One popular example is ClinicalKey (www.clinicalkey.com/info), formerly called MD Consult, which offers books, journals, patient education materials, and images. Another popular portal is Ovid (ovid.com), offering books, journals, evidence-based medicine databases, and CINAHL (Cumulative Index to Nursing and Allied Health Literature).

Electronic journals

Many medical journals now have online databases of current and archived issues. Such sites may require membership to access the databases, so again, check with your medical library. Popular examples in pulmonary and critical care medicine include the following:

Electronic books

Amazon.com is a great database search engine for books on specific topics. It even finds out-of-print books. And you don’t have to buy the books, because now you can rent them. Sometimes, I find what I wanted by using the “Look Inside” feature for some books. Note that you can look for books at PubMed. Just change the search box from PubMed to Books on the PubMed home page. Of course, Google also has a book search feature. A great (subscription) resource for medical and technical books is Safari (https://www.safaribooksonline.com). Once again, your library may have a subscription.

General Internet resources

You probably already know about Google Scholar (scholar.google.com) and Wikipedia.com. Because of its open source nature, you should use Wikipedia with caution. However, I have found it to be a very good first step in finding technical information, particularly about mathematics, physics, and statistics.

 

 

Using reference management software

One of the most important things you can do to make your research life easier is to use some sort of reference management software. As described in Wikipedia, “Reference management software, citation management software or personal bibliographic management software is software for scholars and authors to use for recording and using bibliographic citations (references). Once a citation has been recorded, it can be used time and again in generating bibliographies, such as lists of references in scholarly books, articles, and essays.” I was late in adopting this technology, but now I am a firm believer. Most Internet reference sources offer the ability to download citations to your reference management software. Downloading automatically places the citation into a searchable database on your computer with backup to the Internet. In addition, you can get the reference manager software to find a PDF version of the manuscript and store it with the citation on your computer (and/or in the Cloud) automatically.

But the most powerful feature of such software is its ability to add or subtract and rearrange the order of references in your manuscripts as you are writing, using seamless integration with Microsoft Word. The references can be automatically formatted using just about any journal’s style. This is a great time saver for resubmitting manuscripts to different journals. If you are still numbering references by hand (God forbid) or even using the Insert Endnote feature in Word (deficient when using multiple occurrences of the same reference), your life will be much easier if you take the time to start using reference management software.

The most popular commercial software is probably EndNote (endnote.com). A really good free software system with about the same functionality as Zotero (zotero.com). Search for “comparison of reference management software” in Wikipedia. You can find tutorials on software packages in YouTube.

STUDY DESIGN

Schematic of pre-experimental research designs.
Figure 2. Schematic of pre-experimental research designs.

When designing the experiment, note that there are many different approaches, each with their advantages and disadvantages. A full treatment of this topic is beyond the scope of this article. Suffice it to say that pre-experimental designs (Figure 2) are considered to generate weak evidence. But they are quick and easy and might be appropriate for pilot studies.

Schematic of a quasi-experimental research design.
Figure 3. Schematic of a quasi-experimental research design.

Quasi-experimental designs (Figure 3) generate a higher level of evidence. Such a design might be appropriate when you are stuck with collecting a convenience sample, rather than being able to use a full randomized assignment of study subjects.

The randomized controlled study design.
Figure 4. The randomized controlled study design.

The fully randomized design (Figure 4) generates the highest level of evidence. This is because if the sample size is large enough, the unknown and uncontrollable sources of bias are evenly distributed between the study groups. 

BASIC MEASUREMENT METHODS

If your research involves physical measurements, you need to be familiar with the devices considered to be the gold standards. In cardiopulmonary research, most measurements involve pressure volume, flow, and gas concentration. You need to know which devices are appropriate for static vs dynamic measurements of these variables. In addition, you need to understand issues related to systematic and random measurement errors and how these errors are managed through calibration and calibration verification. I recommend these two textbooks:

Principles and Practice of Intensive Care Monitoring 1st Edition by Martin J. Tobin MD.

  • This book is out of print, but if you can find a used copy or one in a library, it describes just about every kind of physiologic measurement used in clinical medicine.

Medical Instrumentation: Application and Design 4th Edition by John G. Webster.

  • This book is readily available and reasonably priced. It is a more technical book describing medical instrumentation and measurement principles. It is a standard textbook for biometrical engineers.

STATISTICS FOR THE UNINTERESTED

I know what you are thinking: I hate statistics. Look at the book Essential Biostatistics: A Nonmathematical Approach.15 It is a short, inexpensive paperback book that is easy to read. The author does a great job of explaining why we use statistics rather than getting bogged down explaining how we calculate them. After all, novice researchers usually seek the help of a professional statistician to do the heavy lifting.

My book, Handbook for Health Care Research,16 covers most of the statistical procedures you will encounter in medical research and gives examples of how to use a popular tactical software package called SigmaPlot. By the way, I strongly suggest that you consult a statistician early in your study design phase to avoid the disappointment of finding out later that your results are uninterpretable. For an in-depth treatment of the subject, I recommend How to Report Statistics in Medicine.17

Statistical bare essentials

Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data.
Figure 5. Simple graphs that you should be able to make using a spreadsheet program that contains your experimental data. COPD = chronic obstructive pulmonary disease; PaCOs = partial pressure of carbon dioxide, artery; PS = pressure support; RDS = respiratory distress syndrome; SIMV = synchronized intermittent mandatory ventilation

To do research or even just to understand published research reports, you must have at least a minimal skill set. The necessary skills include understanding some basic terminology, if only to be able to communicate with a statistician consultant. Important terms include levels of measurement (nominal, ordinal, continuous), accuracy, precision, measures of central tendency (mean, median, mode), measures of variability (variance, standard deviation, coefficient of variation), and percentile. The first step in analyzing your results is usually to represent it graphically. That means you should be able to use a spreadsheet to make simple graphs (Figure 5).

Example flowchart for selecting the appropriate statistical test.
Figure 6. Example flowchart for selecting the appropriate statistical test. ANOVA = analysis of variance

You should also know the basics of inferential statistics (ie, hypothesis testing). For example, you need to know the difference between parametric and non-parametric tests. You should be able to explain correlation and regression and know when to use Chi-squared vs a Fisher exact test. You should know that when comparing two mean values, you typically use the Student’s t test (and know when to use paired vs unpaired versions of the test). When comparing more than 2 mean values, you use analysis of variance methods (ANOVA). You can teach yourself these concepts from a book,16 but even an introductory college level course on statistics will be immensely helpful. Most statistics textbooks provide some sort of map to guide your selection of the appropriate statistical test (Figure 6), and there are good articles in medical journals.

You can learn a lot simply by reading the Methods section of research articles. Authors will often describe the statistical tests used and why they were used. But be aware that a certain percentage of papers get published with the wrong statistics.18 

One of the underlying assumptions of most parametric statistical methods is that the data may be adequately described by a normal or Gaussian distribution. This assumption needs to be verified before selecting a statistical test. The common test for data normality is the Kolmogorov-Smirnov test. The following text from a methods section describes 2 very common procedures—the Student’s t test for comparing 2 mean values and the one-way ANOVA for comparing more than 2 mean values.19

“Normal distribution of data was verified using the Kolmogorov-Smirnov test. Body weights between groups were compared using one-way ANOVA for repeated measures to investigate temporal differences. At each time point, all data were analyzed using one-way ANOVA to compare PCV and VCV groups. Tukey’s post hoc analyses were performed when significant time effects were detected within groups, and Student’s t test was used to investigate differences between groups. Data were analyzed using commercial software and values were presented as mean ± SD. A P value < .05 was considered statistically significant.” 

 

 

Estimating sample size and power analysis

One very important consideration in any study is the required number of study subjects for meaningful statistical conclusions. In other words, how big should the sample size be? Sample size is important because it affects the feasibility of the study and the reliability of the conclusions in terms of statistical power. The necessary sample size depends on 2 basic factors. One factor is the variability of the data (often expressed as the standard deviation). The other factor is the effect size, meaning, for example, how big of a difference between mean values you want to detect. In general, the bigger the variability and the smaller the difference, the bigger the sample size required.

As the above equation shows, the effect size is expressed, in general, as a mean difference divided by a standard deviation. In the first case, the numerator represents the difference between the sample mean and the assumed population mean. In the denominator, SD is the standard deviation of the sample (used to estimate the standard deviation of the population). In the second case, the numerator represents the difference between the mean values of 2 samples and the denominator is the pooled standard deviation of the 2 samples.

In order to understand the issues involved with selecting sample size, we need to first understand the types of errors that can be made in any type of decision. Suppose our research goal is to make a decision about whether a new treatment results in a clinical difference (improvement). The results of our statistical test are dichotomous—we decide either yes there is a significant difference or no there isn’t. The truth, which we may never know, is that in reality, the difference exists or it doesn’t.

Types of errors in statistical decision making.
Figure 7. Types of errors in statistical decision making.

As Figure 7 shows, the result of our decision making is that there are 2 ways to be right and 2 ways to be wrong. If we decide there is a difference (eg, our statistical tests yields P ≤ .05) but in realty there is not a difference, then we make what is called a type I error. On the other hand, if we conclude that there is not a difference (ie, our statistical test yields P > .05) but in reality there is a difference that we did not detect, then we have made a type II error.

Probabilities associated with type I and type II errors.
Figure 8. Probabilities associated with type I and type II errors.

The associated math is shown in Figure 8. The probability of making a type I error is called alpha. By convention in medicine, we set our rejection criterion to alpha = 0.05. In other words, we would reject the null hypothesis (that there is no difference) anytime our statistical test yields a P value less than alpha. The probability of making a type II error is called beta. For historical reasons, the probability of not making a type II error is called the statistical power of the test and is equal to 1 minus beta. Power is affected by sample size: the larger the sample the larger the power. Most researchers, by convention, keep the sample size large enough to keep power above 0.80.

Nomogram for calculating power and sample size
Figure 9. Nomogram for calculating power and sample size.

Figure 9 is a nomogram that brings all these ideas together. The red line shows that for your study, given the desired effect size (0.8), if you collected samples from the 30 patients you planned on then the power would be unacceptable at 0.60, indicating a high probability of a false negative decision if the P value comes out greater than .50. The solution is to increase the sample size to about 50 (or more), as indicated by the blue line. From this nomogram we can generalize to say that when you want to detect a small effect with data that have high variability, you need a large sample size to provide acceptable power.

The text below is an example of a power analysis presented in the methods section of a published study.20 Note that the authors give their reasoning for the sample size they selected. This kind of explanation may inform your study design. But what if you don’t know the variability of the data you want to collect? In that case, you need to collect some pilot data and calculate from that an appropriate sample size for a subsequent study.

A prospective power calculation indicated that a sample size of 25 per group was required to achieve 80% power based on an effect size of probability of 0.24 that an observation in the PRVCa group is less than an observation in the ASV group using the Mann-Whitney tests, an alpha of 0.05 (two-tailed) and a 20% dropout.

JUDGING FEASIBILITY

Once you have a draft of your study design, including the estimated sample size, it is time to judge the overall feasibility of the study before committing to it.

Factors to consider when judging the feasibility of a new study
Table 1 shows some of the most important factors in judging feasibility. The first question is whether the outcome will be worth the resources needed to complete the study, implying that you must define costs and benefits. Second, assure yourself that you can both define and measure the outcome variables of interest, which can be a challenge in psychological studies and even in quality improvement projects. Next consider the time constraints, which are affected mainly by the sample size and the time needed to observe all the individuals in that sample. Naturally, if you are studying a rare disorder, the time needed to collect even a modest sample size may make the project impractical.

Every study has associated costs. Those costs and the sources of funding must be identified. Don’t forget costs for consultants, particularly if you need statistical consultation.

Finally, consider your level of experience. If you are contemplating your first study, a human clinical trial might not be the best choice, given the complexity of such a project. Studies such as a meta-analysis or mathematical simulation require special training beyond basic research procedures, and should be avoided.

References
  1. Tobin MJ. Mentoring: seven roles and some specifics. Am J Respir Crit Care Med 2004; 170:114–117.
  2. Chatburn RL. Advancing beyond the average: the importance of mentoring in professional achievement. Respir Care 2004; 49:304–308.
  3. Beveridge WIB. The Art of Scientific Investigation. New York, NY: WW Norton & Company; 1950.
  4. Chatburn RL, Mireles-Cabodevila E, Sasidhar M. Tidal volume measurement error in pressure control modes of mechanical ventilation: a model study. Comput Biol Med 2016; 75:235–242.
  5. Mireles-Cabodevila E, Chatburn RL. Work of breathing in adaptive pressure control continuous mandatory ventilation. Respir Care 2009; 54:1467–1472.
  6. Chatburn RL, Ford RM. Procedure to normalize data for benchmarking. Respir Care 2006; 51:145–157.
  7. Bou-Khalil P, Zeineldine S, Chatburn R, et al. Prediction of inspired oxygen fraction for targeted arterial oxygen tension following open heart surgery in non-smoking and smoking patients. J Clin Monit Comput 2016. https://doi.org/10.1007/s10877-016-9941-6.
  8. Mireles-Cabodevila E, Diaz-Guzman E, Arroliga AC, Chatburn RL. Human versus computer controlled selection of ventilator settings: an evaluation of adaptive support ventilation and mid-frequency ventilation. Crit Care Res Pract 2012; 2012:204314.
  9. Chatburn RL. How to find the best evidence. Respir Care 2009; 54:1360–1365.
  10. Durbin CG Jr. How to read a scientific research paper. Respir Care 2009; 54:1366–1371.
  11. Pierson DJ. How to read a case report (or teaching case of the month). Respir Care 2009; 54:1372–1378.
  12. Callcut RA, Branson RD. How to read a review paper. Respir Care 2009; 54:1379–1385.
  13. Eresuma E, Lake E. How do I find the evidence? Find your librarian—stat! Orthop Nurs 2016; 35:421–423.
  14. Janke R, Rush KL. The academic librarian as co-investigator on an interprofessional primary research team: a case study. Health Info Libr J 2014; 31:116–122.
  15. Motulsky H. Essential Biostatistics: A Nonmathematical Approach. New York, NY: Oxford University Press; 2016.
  16. Chatburn RL. Handbook for Health Care Research. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2011.
  17. Lang TA, Secic M. How to Report Statistics in Medicine. 2nd ed. Philadelphia, PA: American College of Physicians; 2006.
  18. Prescott RJ, Civil I. Lies, damn lies and statistics: errors and omission in papers submitted to INJURY 2010–2012. Injury 2013; 44:6–11.
  19. Fantoni DT, Ida KK, Lopes TF, Otsuki DA, Auler JO Jr, Ambrosio AM. A comparison of the cardiopulmonary effects of pressure controlled ventilation and volume controlled ventilation in healthy anesthetized dogs. J Vet Emerg Crit Care (San Antonio) 2016; 26:524–530.
  20. Gruber PC, Gomersall CD, Leung P, et al. Randomized controlled trial comparing adaptive-support ventilation with pressure-regulated volume-controlled ventilation with automode in weaning patients after cardiac surgery. Anesthesiology 2008; 109:81–87.
References
  1. Tobin MJ. Mentoring: seven roles and some specifics. Am J Respir Crit Care Med 2004; 170:114–117.
  2. Chatburn RL. Advancing beyond the average: the importance of mentoring in professional achievement. Respir Care 2004; 49:304–308.
  3. Beveridge WIB. The Art of Scientific Investigation. New York, NY: WW Norton & Company; 1950.
  4. Chatburn RL, Mireles-Cabodevila E, Sasidhar M. Tidal volume measurement error in pressure control modes of mechanical ventilation: a model study. Comput Biol Med 2016; 75:235–242.
  5. Mireles-Cabodevila E, Chatburn RL. Work of breathing in adaptive pressure control continuous mandatory ventilation. Respir Care 2009; 54:1467–1472.
  6. Chatburn RL, Ford RM. Procedure to normalize data for benchmarking. Respir Care 2006; 51:145–157.
  7. Bou-Khalil P, Zeineldine S, Chatburn R, et al. Prediction of inspired oxygen fraction for targeted arterial oxygen tension following open heart surgery in non-smoking and smoking patients. J Clin Monit Comput 2016. https://doi.org/10.1007/s10877-016-9941-6.
  8. Mireles-Cabodevila E, Diaz-Guzman E, Arroliga AC, Chatburn RL. Human versus computer controlled selection of ventilator settings: an evaluation of adaptive support ventilation and mid-frequency ventilation. Crit Care Res Pract 2012; 2012:204314.
  9. Chatburn RL. How to find the best evidence. Respir Care 2009; 54:1360–1365.
  10. Durbin CG Jr. How to read a scientific research paper. Respir Care 2009; 54:1366–1371.
  11. Pierson DJ. How to read a case report (or teaching case of the month). Respir Care 2009; 54:1372–1378.
  12. Callcut RA, Branson RD. How to read a review paper. Respir Care 2009; 54:1379–1385.
  13. Eresuma E, Lake E. How do I find the evidence? Find your librarian—stat! Orthop Nurs 2016; 35:421–423.
  14. Janke R, Rush KL. The academic librarian as co-investigator on an interprofessional primary research team: a case study. Health Info Libr J 2014; 31:116–122.
  15. Motulsky H. Essential Biostatistics: A Nonmathematical Approach. New York, NY: Oxford University Press; 2016.
  16. Chatburn RL. Handbook for Health Care Research. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2011.
  17. Lang TA, Secic M. How to Report Statistics in Medicine. 2nd ed. Philadelphia, PA: American College of Physicians; 2006.
  18. Prescott RJ, Civil I. Lies, damn lies and statistics: errors and omission in papers submitted to INJURY 2010–2012. Injury 2013; 44:6–11.
  19. Fantoni DT, Ida KK, Lopes TF, Otsuki DA, Auler JO Jr, Ambrosio AM. A comparison of the cardiopulmonary effects of pressure controlled ventilation and volume controlled ventilation in healthy anesthetized dogs. J Vet Emerg Crit Care (San Antonio) 2016; 26:524–530.
  20. Gruber PC, Gomersall CD, Leung P, et al. Randomized controlled trial comparing adaptive-support ventilation with pressure-regulated volume-controlled ventilation with automode in weaning patients after cardiac surgery. Anesthesiology 2008; 109:81–87.
Page Number
e10-e19
Page Number
e10-e19
Publications
Publications
Article Type
Display Headline
Basics of study design: Practical considerations
Display Headline
Basics of study design: Practical considerations
Legacy Keywords
study design, statistics, hypothesis testing, sample size, power, Robert Chatburn
Legacy Keywords
study design, statistics, hypothesis testing, sample size, power, Robert Chatburn
Citation Override
Cleveland Clinic Journal of Medicine 2017 September;84(suppl 2):e10-e19
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Article PDF Media

Airway pressure release ventilation: An alternative mode of mechanical ventilation in acute respiratory distress syndrome

Article Type
Changed
Thu, 10/19/2017 - 10:06
Display Headline
Airway pressure release ventilation: An alternative mode of mechanical ventilation in acute respiratory distress syndrome

In the early stages of acute respiratory distress syndrome (ARDS), multiple areas of the lung collapse, most often in the dependent regions. A factor involved in this process is the loss of functional surfactant, creating a condition in which alveolar units are unstable and prone to collapse due to unopposed surface tension. This situation, similar to that in premature infants, results in a reduced volume of aerated lung, intrapulmonary shunting, and, therefore, poor oxygenation.

The treatment of this alveolar collapse is lung reinflation (or “recruitment,” a term first used by Lachmann).1 Gattinoni et al2 showed that the percentage of recruitable lung could range from a negligible fraction to 50% or more.

There are various means of reopening injured lungs and keeping them open. The choice of recruitment maneuver is based on the individual patient and the ventilatory mode.3

In this article, we review airway pressure release ventilation (APRV), a mode of mechanical ventilation that may be useful in situations in which, due to ARDS, the lungs need to be recruited and held open. APRV was developed as a lung-protective mode, allowing recruitment while minimizing ventilator-induced lung injury.

BASIC PRINCIPLES OF PROTECTIVE VENTILATION

Figure 1.
If we draw a graph with the pressure in the lung on the horizontal axis and the volume on the vertical axis, the result is called the compliance curve (Figure 1).

This curve has two inflection points between which its slope is steep, indicating greater compliance or elasticity. Below the lower inflection point, the alveoli may collapse; above the upper inflection point, the lung loses its elastic properties and the alveoli are overdistended. To protect the lungs, the challenge in mechanical ventilation is to keep the lungs between these two points throughout the respiratory cycle.

Avoiding lung collapse by using PEEP

During mechanical ventilation, the pressure in the lungs is lowest, and thus the alveoli are most prone to collapse, at the end of expiration.

We want to prevent the alveoli from collapsing with each expiration and reopening with each inspiration, as this cycle of opening and closing damages them (causing atelectrauma, ie, cyclical atelectasis).4 Preventing it prevents the release of inflammatory mediators and the perpetuation of lung injury (biotrauma).5

The solution is to apply positive end-expiratory pressure (PEEP), taking into account the value of the lower inflection point when setting the PEEP level.

Villar et al6 compared outcomes in an intervention group that received a PEEP level 2 cm H2O above the lower inflection point plus low tidal volumes, and in a control group that received higher tidal volumes and low PEEP (5 cm H2O). The study was stopped early, after significantly more patients had died in the control group than in the intervention group (53% vs 32%, P = .04).

Avoiding overdistention by keeping the tidal volume low

Tidal volumes that exceed the upper inflection point overstretch the lung and induce volutrauma, which can manifest as pneumothorax or pneumomediastinum, or both—the lungs rupture like a balloon. Also, overdistention produces liberation of inflammatory mediators in the blood (biotrauma). High tidal volumes should therefore be avoided or limited as much as possible.

The ARDS Network,7 in a multicenter, randomized, controlled trial, showed that fewer patients die if they receive mechanical ventilation with low tidal volumes rather than higher, “conventional” tidal volumes. Patients were randomized to receive either a tidal volume of 6 mL/kg and a plateau pressure lower than 30 cm H2O or a tidal volume of 12 mL/kg and a plateau pressure lower than 50 cm H2O. They were followed for 180 days or until discharged home, breathing without assistance. A total of 861 patients were enrolled. The mortality rate was significantly lower in the low tidal volume group than in the group with conventional tidal volumes, 31% vs 40%.

Lower tidal volumes were also associated with faster attenuation of the inflammatory response.8

Amato et al9 randomized 58 patients to receive mechanical ventilation with tidal volumes of either 6 mL/kg or 12 mL/kg. The PEEP level was maintained above the lower inflection point. At 28 days, 62% of the patients in the intervention group were still alive, compared with only 29% in the control group. However, many concerns were expressed over the high mortality rate in the control group.

Based on these studies, the use of low tidal volumes with appropriate levels of PEEP to ensure lung recruitment is the current standard of care in mechanical ventilation of patients with ARDS.10

 

 

APRV: A PRESSURE-CONTROLLED MODE THAT ALLOWS SPONTANEOUS BREATHS

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 2.
Airway pressure release ventilation (APRV), first described by Stock et al in 1987,11 is essentially a pressure-control mode—ie, the clinician sets a high and a low pressure. However, it also allows spontaneous breathing through the entire breathing cycle (Figure 2).12,13

A baseline high pressure (P high) is set first. Mandatory breaths are achieved by releasing the high baseline pressure in the circuit very briefly, usually to 0 cm H2O (P low), which allows the lungs to partially deflate, and then quickly resuming the high pressure before the unstable alveoli can collapse.

In theory, the optimal release time (the very short time in low pressure, or T low) in APRV should be determined by the time constant of the expiratory flow. The time constant (t) is the time it takes to empty 63% of the lung volume. It is calculated as:

t = C × R

where C is the combined compliance of the lung and chest wall, and R is the combined resistance of the endotracheal tube and the natural airways. In diseases that lead to lower lung compliance (such as ARDS), the time constant is shorter. A practical equilibrium time—or the time it takes for the lung volume in expiration to reach steady state (no expiratory flow)—is about 4 time constants.14

Since the release time in APRV is much shorter than the equilibrium time, a residual volume of air remains in the lung, creating intentional auto-PEEP. Ideally, this intentional auto-PEEP should be high enough to avoid derecruitment (optimally above the lower inflection point). In APRV the auto-PEEP is controlled by the settings, and this intentional restriction of the expiratory flow is critical to avoid derecruitment of unstable alveolar units.

The amount of time spent at the higher pressure (T high) is generally 80% to 95% of the cycle (ie, the lungs are “inflated” 80% to 95% of the time), and the amount of time at the lower pressure (T low) is 0.6 to 0.8 seconds.

Thus, APRV settings provide a relatively high mean airway pressure, which prevents collapse of unstable alveoli and over time recruits additional alveolar units in the injured lung. The major difference between this mode and more conventional modes is that in APRV the mean inspiratory pressure is maximized and end-expiratory pressure is due to intentional auto-PEEP. In addition, spontaneous breathing is allowed throughout the entire cycle (Figure 2).13

Although APRV does not approximate the physiology of spontaneous breathing with healthy lungs, it is nonetheless relatively comfortable and well tolerated. Its theoretical advantage in patients with lung injury is its ability to maximize alveoli recruitment by maintaining a higher mean inspiratory pressure, while the peak alveolar pressure remains lower than with conventional ventilation (Figure 1).

Other modes that are similar to APRV

Other modes of mechanical ventilation very similar to APRV are biphasic positive airway pressure (BiPAP) and bilevel ventilation.

BiPAP differs from APRV only in the timing of the upper and lower pressure levels. In BiPAP, T high is usually shorter than T low. Therefore, in order to avoid derecruitment, P low has to be set above zero with both a high and a low PEEP level.13

No studies have demonstrated one mode to be more beneficial than the other, although BiPAP might be more predictable, as both pressures are known.

Bilevel ventilation works like APRV but incorporates pressure support to spontaneous breathing. The use of pressure support may affect the positive physiologic effects (see section below) of unsupported spontaneous breathing. Nevertheless, this strategy might be useful to address severe hypercapnia in the context of APRV.

INITIAL VENTILATOR SETTINGS IN APRV

As we described in the previous section, P high and T high are set to increase end-inspiratory lung volume, recruitment, and oxygenation. P low and T low regulate end-expiratory lung volume, and their settings should prevent derecruitment but ensure adequate alveolar ventilation (Table 1).

P high. In selecting an initial P high, we measure the plateau pressure in a conventional mode using an accepted protective strategy, such as volume-control mode. If the plateau pressure is lower than 30 cm H2O, we use this pressure as our initial P high. If the plateau pressure is higher than 30 cm H2O, we select 30 cm H2O as an initial P high to minimize peak alveolar pressure and reduce the risk of lung overdistention.

P low is set at 0 cm H2O.

T high is set at 4 seconds and is then adjusted if necessary.

T low is probably the most difficult variable to set because it needs to be short enough to avoid derecruitment but still long enough to allow alveolar ventilation. We usually start with a T low of 0.6 to 0.8 seconds.

ADJUSTING THE VENTILATOR SETTINGS

For hypoxemia. Physician-controlled variables that affect oxygenation in APRV are:

  • Mean airway pressure (dependent primarily on P high and T high)
  • Fraction of inspired oxygen (Fio2).

Inadequate oxygenation usually requires increasing one or both of these settings.

Physician-controlled variables that affect alveolar ventilation in the APRV mode are:

  • Pressure gradient (P high minus P low)
  • Airway pressure release time (T low)
  • Airway pressure release frequency.14 Frequency is related to total cycle time of mandatory breaths by the following equation3:

frequency = 60/cycle time = 60/(T high + T low).

Note that if T low remains constant, adjusting T high will adjust frequency (the more time the lung remains inflated, the lower the respiratory frequency). Conversely, some ventilators allow adjustment of frequency, making T high the dependent variable. The goal of this mode is to recruit alveoli and improve oxygenation, so we usually do not modify the pressure gradient to improve ventilation.

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 3.
In practice, physicians rarely calculate the time constant for each patient to set T low. Hence, T low is usually adjusted according to the flow-time curve on the ventilator, so that the pressure release ends when expiratory flow reaches approximately 40% of the peak expiratory flow, ie, approximately 1 time constant (Figure 3).13

For hypercapnia. A frequent and expected consequence of lung-protective ventilation strategies is hypercapnia, termed “permissive” hypercapnia because it is allowed to some extent. In APRV, some degree of CO2 retention is not unusual. When the measured Paco2 becomes extreme, we usually increase the frequency of releases by shortening T high, recognizing that this adjustment may affect recruitment by lowering the mean airway pressure.

Spontaneous breaths. A positive aspect of APRV that contributes to its tolerability for patients is that it allows for spontaneous respiration. In some studies of patients with ARDS ventilated with APRV, spontaneous breathing accounted for 10% to 30% of the total minute ventilation and was responsible for an improvement in ventilation-perfusion matching and oxygenation.15,16 We titrate our patients’ sedation to a goal of spontaneous breathing of at least 10% of total minute ventilation.

 

 

WEANING FROM APRV

Weaning from APRV is done carefully to avoid derecruitment. Some authors recommend lowering P high by 2 to 3 cm H2O at a time and lengthening T high by increments of 0.5 to 2.0 seconds.13,17

Once P high is about 16 cm H2O, T high is at 12 to 15 seconds, and spontaneous respiration accounts for most or all of the minute volume, the mode can be changed to continuous positive airway pressure (CPAP) and titrated downwards. Usually, when CPAP is at 5 to 10 cm H2O, the patient is extubated, provided that mental status or concerns about airway protection or secretions are not contraindications.

PHYSIOLOGIC EFFECTS OF APRV WITH SPONTANEOUS BREATHING

Effects on the respiratory system

During spontaneous breathing, the greatest displacement of the diaphragm is in dependent regions. These regions are the best ventilated.18 Compared with spontaneously breathing patients, mechanically ventilated patients have a smaller inspiratory displacement of the dependent part of the lung.19

A study using computed tomography demonstrated that the reduction of lung volume observed in patients with acute lung injury (ALI) predominantly affects the lower lobes (dependent areas).20 Causative mechanisms could be an increase in lung weight related to ALI and a passive collapse of the lower lobes associated with an upward shift of the diaphragm.

In a preliminary study, the topographic distribution of lung collapse was different in spontaneously breathing ARDS patients than in patients who were paralyzed. In particular, lung densities were not concentrated in the dependent regions in the former group.21

Oxygenation is better with APRV with spontaneous breathing than with mechanical ventilation alone. This effect is at least partly attributable to recruitment of collapsed lung tissue and increased aeration of the dependent areas of the lung.22

Putensen et al15 compared ventilation-perfusion distribution in 24 patients with ARDS who were randomized to APRV with spontaneous breathing (more than 10% of the total minute ventilation), APRV without spontaneous breathing, or pressure-support ventilation. Spontaneous breathing during APRV improved ventilation-perfusion matching and increased systemic blood flow.

Neumann et al23 recently compared the effect of APRV with spontaneous breathing vs APRV without spontaneous breathing in terms of ventilation perfusion in an animal model of lung injury. APRV with spontaneous breathing increased ventilation in juxta-diaphragmatic regions, predominantly in dependent areas. Spontaneous breathing had a significant effect on the spatial distribution of ventilation and pulmonary perfusion.

Based on these studies, we generally use APRV with no pressure support. This strategy permits recruitment and expansion of dependent lung areas.

Effects on the cardiovascular system and hemodynamics

Räsänen et al,24 in an animal model, compared cardiovascular performance during APRV, spontaneous breathing, and continuous positive pressure ventilation. No significant differences in cardiovascular function were detected between APRV and spontaneous breathing. In contrast, continuous positive pressure ventilation decreased blood pressure, stroke volume, cardiac output, and oxygen delivery.

Falkenhain et al,25 in a subsequent case report, found that a change in mode from intermittent mandatory ventilation with PEEP to APRV resulted in improvement in the cardiac output of a patient requiring mechanical ventilation.

The lack of deleterious effect of APRV on cardiovascular function is probably a result of its spontaneous breathing component. The reduction in mean intrathoracic pressure during spontaneous breathing (compared to paralysis) improves venous return and biventricular filling, boosting cardiac output and oxygen delivery.26

Hering et al27 compared APRV with spontaneous breathing (at least 30% of the total minute ventilation) vs APRV with no spontaneous breathing in 12 patients with ALI. This study showed higher renal blood flow, glomerular filtration, and osmolar clearance in the APRV-with-spontaneous-breathing group.

The same investigators evaluated the effects of spontaneous breathing with APRV on intestinal blood flow in an animal model of lung injury.28 Spontaneous breathing with APRV improved arterial oxygenation, the systemic hemodynamic profile, and regional perfusion to the stomach and small bowel compared with full ventilatory support.

ANIMAL STUDIES OF APRV

Stock et al,11 in their original description of APRV in 1987, reported experimental results in dogs. In that study, 10 dogs with and without ARDS were randomized to APRV with a custom-built device vs volume-control mode with a Harvard pump ventilator plus PEEP. APRV delivered adequate alveolar ventilation, had lower peak airway pressures, and promoted better arterial oxygenation (at the same tidal volume and mean airway pressure) compared with volume control.

Martin et al (1991)29 studied seven neonatal lambs with ALI with four ventilatory modes: pressure-support ventilation, APRV, volume control, and spontaneous breathing. APRV maintained oxygenation while augmenting alveolar ventilation compared with pressure-support ventilation. APRV also provided ventilation at a lower peak pressure in contrast to volume control. The authors concluded that APRV was an effective mode to maintain oxygenation and assist alveolar ventilation with minimal cardiovascular impact in their animal model of ALI.

 

 

HUMAN STUDIES OF APRV

Garner et al (1988)30 studied 14 patients after operative coronary revascularization, giving them volume control mode (12 mL/kg) and then, when they were hemodynamically stable, APRV. While APRV and volume control supported ventilation and arterial oxygenation equally in all cases, peak airway pressure was greater with volume control.

Räsänen et al (1991)31 designed a prospective, multicenter, crossover trial in which 50 patients with ALI were ventilated with conventional ventilation and subsequently with APRV. Patients in both groups were adequately ventilated and oxygenated. However, as described in the aforementioned study,24 the peak airway pressure was lower in the APRV group.

Davis et al (1993)32 studied 15 patients with ARDS requiring ventilatory support who received intermittent mandatory ventilation plus PEEP and then were placed on APRV. Peak airway pressure was lower, but mean airway pressure was higher with APRV. There were no statistically significant differences in gas exchange or hemodynamic variables.

Putensen et al,33 in a study designed on the basis of prior publications,15 randomized 30 patients with multiple trauma to either APRV with spontaneous breathing (n = 15) or pressure-control ventilation (n = 15) for 72 hours. Weaning was performed with APRV in both groups. APRV was associated with increases in lung compliance and oxygenation and reduction of shunting. Interestingly, the use of APRV was associated with shorter duration of ventilatory support (15 vs 21 days), shorter length of intensive care unit stay (23 vs 30 days), and shorter duration of sedation and use of vasopressors.

An important confounder in this trial was that all patients on pressure-control ventilation were initially paralyzed, favoring the APRV group.

Varpula and colleagues34 performed a prospective randomized intervention study to determine whether the response of oxygenation to the prone position differed between APRV vs pressure-controlled synchronized intermittent mandatory ventilation with pressure support. Forty-five patients with ALI were randomized within 72 hours of initiation of mechanical ventilation to receive one of these two modes; 33 ultimately received the assigned treatment. All patients were positioned on their stomachs for 6 hours once or twice a day. The response in terms of oxygenation to the first pronation was similar in both groups, whereas there was a significant improvement after the second pronation in the APRV group. The authors concluded that prone positioning and allowance of spontaneous breathing during APRV had advantageous effects on gas exchange.

In 2004, the same investigators35 randomized 58 patients with ALI after stabilization to either APRV or pressure-controlled synchronized intermittent mandatory ventilation. There were no significant differences in the clinically important outcomes such as ventilator-free days, sedation days, need of hemodialysis, or intensive care unit-free days.

Dart et al,36 in a retrospective study of 46 trauma patients who were ventilated with APRV for 72 hours, found an improvement in the Pao2/Fio2 ratio and a decrement in peak airway pressure after APRV was started.

In conclusion, most studies show physiologic benefits and improvement in some clinical outcomes, such as oxygenation, use of sedation, hemodynamic variables, and respiratory mechanics. However, no studies report that APRV decreases the mortality rate compared with conventional protective ventilation.

Table 2 summarizes the randomized clinical trials of APRV.33–35,37

CONCERNS ABOUT APRV

Overstretching. One of the major concerns when applying APRV is overstretching the lung parenchyma.26,38 It is important to recognize that, when choosing a P high setting, this variable is not the only determinant of the tidal volume. Spontaneous breathing causes the pleural pressure to become less positive. As a result, there is an increase in the transpulmonary pressure (pressure in alveoli minus pressure in the pleura). This augmentation of transpulmonary pressure will result in a higher tidal volume and the risk of overdistention and volume-induced lung injury.

Atelectrauma. As mentioned earlier, damage may occur when airways open and close with each tidal cycle. This is particularly worrisome when the end-expiratory pressure is below the lower inflection point, as some diseased alveolar units may collapse. In APRV, the airway pressure is released to zero. Even though the intentional auto-PEEP might maintain a certain end-expiratory pressure, this parameter is truly uncontrolled.39

If the patient cannot breath spontaneously. Another consideration is that many of the benefits of APRV are based on the spontaneous breathing component. Unfortunately, patients who need heavy sedation or neuromuscular paralysis with lack of spontaneous breathing efforts may lose the physiologic advantages of this mode.

Possible contraindications to APRV include conditions that may worsen with the elevation of the mean airway pressure, such as unmanaged increases of intracranial pressure and large bronchopleural fistulas.

Despite these limitations, APRV presents many attractive benefits as an alternative mode of mechanical ventilation in patients who do not respond to conventional modes.

Table 3 summarizes the advantages and disadvantages of each component of APRV.

References
  1. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18:319321.
  2. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:17751786.
  3. Papadakos PJ, Lachmann B. The open lung concept of mechanical ventilation: the role of recruitment and stabilization. Crit Care Clin 2007; 23:241250,
  4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:13341349.
  5. Dreyfuss D, Saumon G, Hubmayr RD, editors. Ventilator-induced Lung Injury. New York: Taylor & Francis, 2006.
  6. Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34:13111318.
  7. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:13011308.
  8. Parsons PE, Eisner MD, Thompson BT, et al; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:16.
  9. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347354.
  10. Hemmila MR, Napolitano LM. Severe respiratory failure: advanced treatment options. Crit Care Med 2006; 34( suppl 9):S278S290.
  11. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med 1987; 15:462466.
  12. Chatburn RL. Classification of ventilator modes: update and proposal for implementation. Respir Care 2007; 52:301323.
  13. Martin LD, Wetzel RC. Optimal release time during airway pressure release ventilation in neonatal sheep. Crit Care Med 1994; 22:486493.
  14. Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clin Issues 2001; 12:234246.
  15. Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:12411248.
  16. Putensen C, Wrigge H. Clinical review: biphasic positive airway pressure and airway pressure release ventilation. Crit Care 2004; 8:492497.
  17. Habashi NM. Other approaches to open-lung ventilation: airway pressure release ventilation. Crit Care Med 2005; 33( suppl 3):S228S240.
  18. Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41:242255.
  19. Reber A, Nylund U, Hedenstierna G. Position and shape of the diaphragm: implications for atelectasis formation. Anaesthesia 1998; 53:10541061.
  20. Puybasset L, Cluzel P, Chao N, Slutsky AS, Coriat P, Rouby JJ. A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group. Am J Respir Crit Care Med 1998; 158:16441655.
  21. Gattinoni L, Presenti A, Torresin A, et al. Adult respiratory distress syndrome profiles by computed tomography. J Thorac Imaging 1986; 1:2530.
  22. Hedenstierna G, Lichtwarck-Aschoff M. Interfacing spontaneous breathing and mechanical ventilation. New insights. Minerva Anestesiol 2006; 72:183198.
  23. Neumann P, Wrigge H, Zinserling J, et al. Spontaneous breathing affects the spatial ventilation and perfusion distribution during mechanical ventilatory support. Crit Care Med 2005; 33:10901095.
  24. Räsänen J, Downs JB, Stock MC. Cardiovascular effects of conventional positive pressure ventilation and airway pressure release ventilation. Chest 1988; 93:911915.
  25. Falkenhain SK, Reilley TE, Gregory JS. Improvement in cardiac output during airway pressure release ventilation. Crit Care Med 1992; 20:13581360.
  26. Siau C, Stewart TE. Current role of high frequency oscillatory ventilation and airway pressure release ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2008; 29:265275.
  27. Hering R, Peters D, Zinserling J, Wrigge H, von Spiegel T, Putensen C. Effects of spontaneous breathing during airway pressure release ventilation on renal perfusion and function in patients with acute lung injury. Intensive Care Med 2002; 28:14261433.
  28. Hering R, Viehöfer A, Zinserling J, et al. Effects of spontaneous breathing during airway pressure release ventilation on intestinal blood flow in experimental lung injury. Anesthesiology 2003; 99:11371144.
  29. Martin LD, Wetzel RC, Bilenki AL. Airway pressure release ventilation in a neonatal lamb model of acute lung injury. Crit Care Med 1991; 19:373378.
  30. Garner W, Downs JB, Stock MC, Räsänen J. Airway pressure release ventilation (APRV). A human trial. Chest 1988; 94:779781.
  31. Räsänen J, Cane RD, Downs JB, et al. Airway pressure release ventilation during acute lung injury: a prospective multicenter trial. Crit Care Med 1991; 19:12341241.
  32. Davis K, Johnson DJ, Branson RD, Campbell RS, Johannigman JA, Porembka D. Airway pressure release ventilation. Arch Surg 1993; 128:13481352.
  33. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001; 164:4349.
  34. Varpula T, Jousela I, Niemi R, Takkunen O, Pettilä V. Combined effects of prone positioning and airway pressure release ventilation on gas exchange in patients with acute lung injury. Acta Anaesthesiol Scand 2003; 47:516524.
  35. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004; 48:722731.
  36. Dart BW, Maxwell RA, Richart CM, et al. Preliminary experience with airway pressure release ventilation in a trauma/surgical intensive care unit. J Trauma 2005; 59:7176.
  37. Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-term effects of two different ventilatory modes on oxygenation in acute lung injury. Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation. Am J Respir Crit Care Med 1994; 149:15501556.
  38. Neumann P, Golisch W, Strohmeyer A, Buscher H, Burchardi H, Sydow M. Influence of different release times on spontaneous breathing pattern during airway pressure release ventilation. Intensive Care Med 2002; 28:17421749.
  39. Dries DJ, Marini JJ. Airway pressure release ventilation. J Burn Care Res 2009; 30:929936.
Article PDF
Author and Disclosure Information

Ariel Modrykamien, MD, FCCP, FACP
Assistant Professor of Medicine, Pulmonary, Sleep and Critical Care Medicine Division, Creighton University School of Medicine, Omaha, NE

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Department of Respiratory Therapy, Cleveland Clinic

Rendell W. Ashton, MD
Respiratory Institute, Cleveland Clinic

Address: Ariel Modrykamien, MD, FCCP, FACP, Respiratory Institute, A90, Cleveland Clinic, 9500 Euclid Avenue. Cleveland OH 44195; e-mail amodry@gmail.com

Issue
Cleveland Clinic Journal of Medicine - 78(2)
Publications
Topics
Page Number
101-110
Sections
Author and Disclosure Information

Ariel Modrykamien, MD, FCCP, FACP
Assistant Professor of Medicine, Pulmonary, Sleep and Critical Care Medicine Division, Creighton University School of Medicine, Omaha, NE

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Department of Respiratory Therapy, Cleveland Clinic

Rendell W. Ashton, MD
Respiratory Institute, Cleveland Clinic

Address: Ariel Modrykamien, MD, FCCP, FACP, Respiratory Institute, A90, Cleveland Clinic, 9500 Euclid Avenue. Cleveland OH 44195; e-mail amodry@gmail.com

Author and Disclosure Information

Ariel Modrykamien, MD, FCCP, FACP
Assistant Professor of Medicine, Pulmonary, Sleep and Critical Care Medicine Division, Creighton University School of Medicine, Omaha, NE

Robert L. Chatburn, MHHS, RRT-NPS, FAARC
Clinical Research Manager, Department of Respiratory Therapy, Cleveland Clinic

Rendell W. Ashton, MD
Respiratory Institute, Cleveland Clinic

Address: Ariel Modrykamien, MD, FCCP, FACP, Respiratory Institute, A90, Cleveland Clinic, 9500 Euclid Avenue. Cleveland OH 44195; e-mail amodry@gmail.com

Article PDF
Article PDF
Related Articles

In the early stages of acute respiratory distress syndrome (ARDS), multiple areas of the lung collapse, most often in the dependent regions. A factor involved in this process is the loss of functional surfactant, creating a condition in which alveolar units are unstable and prone to collapse due to unopposed surface tension. This situation, similar to that in premature infants, results in a reduced volume of aerated lung, intrapulmonary shunting, and, therefore, poor oxygenation.

The treatment of this alveolar collapse is lung reinflation (or “recruitment,” a term first used by Lachmann).1 Gattinoni et al2 showed that the percentage of recruitable lung could range from a negligible fraction to 50% or more.

There are various means of reopening injured lungs and keeping them open. The choice of recruitment maneuver is based on the individual patient and the ventilatory mode.3

In this article, we review airway pressure release ventilation (APRV), a mode of mechanical ventilation that may be useful in situations in which, due to ARDS, the lungs need to be recruited and held open. APRV was developed as a lung-protective mode, allowing recruitment while minimizing ventilator-induced lung injury.

BASIC PRINCIPLES OF PROTECTIVE VENTILATION

Figure 1.
If we draw a graph with the pressure in the lung on the horizontal axis and the volume on the vertical axis, the result is called the compliance curve (Figure 1).

This curve has two inflection points between which its slope is steep, indicating greater compliance or elasticity. Below the lower inflection point, the alveoli may collapse; above the upper inflection point, the lung loses its elastic properties and the alveoli are overdistended. To protect the lungs, the challenge in mechanical ventilation is to keep the lungs between these two points throughout the respiratory cycle.

Avoiding lung collapse by using PEEP

During mechanical ventilation, the pressure in the lungs is lowest, and thus the alveoli are most prone to collapse, at the end of expiration.

We want to prevent the alveoli from collapsing with each expiration and reopening with each inspiration, as this cycle of opening and closing damages them (causing atelectrauma, ie, cyclical atelectasis).4 Preventing it prevents the release of inflammatory mediators and the perpetuation of lung injury (biotrauma).5

The solution is to apply positive end-expiratory pressure (PEEP), taking into account the value of the lower inflection point when setting the PEEP level.

Villar et al6 compared outcomes in an intervention group that received a PEEP level 2 cm H2O above the lower inflection point plus low tidal volumes, and in a control group that received higher tidal volumes and low PEEP (5 cm H2O). The study was stopped early, after significantly more patients had died in the control group than in the intervention group (53% vs 32%, P = .04).

Avoiding overdistention by keeping the tidal volume low

Tidal volumes that exceed the upper inflection point overstretch the lung and induce volutrauma, which can manifest as pneumothorax or pneumomediastinum, or both—the lungs rupture like a balloon. Also, overdistention produces liberation of inflammatory mediators in the blood (biotrauma). High tidal volumes should therefore be avoided or limited as much as possible.

The ARDS Network,7 in a multicenter, randomized, controlled trial, showed that fewer patients die if they receive mechanical ventilation with low tidal volumes rather than higher, “conventional” tidal volumes. Patients were randomized to receive either a tidal volume of 6 mL/kg and a plateau pressure lower than 30 cm H2O or a tidal volume of 12 mL/kg and a plateau pressure lower than 50 cm H2O. They were followed for 180 days or until discharged home, breathing without assistance. A total of 861 patients were enrolled. The mortality rate was significantly lower in the low tidal volume group than in the group with conventional tidal volumes, 31% vs 40%.

Lower tidal volumes were also associated with faster attenuation of the inflammatory response.8

Amato et al9 randomized 58 patients to receive mechanical ventilation with tidal volumes of either 6 mL/kg or 12 mL/kg. The PEEP level was maintained above the lower inflection point. At 28 days, 62% of the patients in the intervention group were still alive, compared with only 29% in the control group. However, many concerns were expressed over the high mortality rate in the control group.

Based on these studies, the use of low tidal volumes with appropriate levels of PEEP to ensure lung recruitment is the current standard of care in mechanical ventilation of patients with ARDS.10

 

 

APRV: A PRESSURE-CONTROLLED MODE THAT ALLOWS SPONTANEOUS BREATHS

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 2.
Airway pressure release ventilation (APRV), first described by Stock et al in 1987,11 is essentially a pressure-control mode—ie, the clinician sets a high and a low pressure. However, it also allows spontaneous breathing through the entire breathing cycle (Figure 2).12,13

A baseline high pressure (P high) is set first. Mandatory breaths are achieved by releasing the high baseline pressure in the circuit very briefly, usually to 0 cm H2O (P low), which allows the lungs to partially deflate, and then quickly resuming the high pressure before the unstable alveoli can collapse.

In theory, the optimal release time (the very short time in low pressure, or T low) in APRV should be determined by the time constant of the expiratory flow. The time constant (t) is the time it takes to empty 63% of the lung volume. It is calculated as:

t = C × R

where C is the combined compliance of the lung and chest wall, and R is the combined resistance of the endotracheal tube and the natural airways. In diseases that lead to lower lung compliance (such as ARDS), the time constant is shorter. A practical equilibrium time—or the time it takes for the lung volume in expiration to reach steady state (no expiratory flow)—is about 4 time constants.14

Since the release time in APRV is much shorter than the equilibrium time, a residual volume of air remains in the lung, creating intentional auto-PEEP. Ideally, this intentional auto-PEEP should be high enough to avoid derecruitment (optimally above the lower inflection point). In APRV the auto-PEEP is controlled by the settings, and this intentional restriction of the expiratory flow is critical to avoid derecruitment of unstable alveolar units.

The amount of time spent at the higher pressure (T high) is generally 80% to 95% of the cycle (ie, the lungs are “inflated” 80% to 95% of the time), and the amount of time at the lower pressure (T low) is 0.6 to 0.8 seconds.

Thus, APRV settings provide a relatively high mean airway pressure, which prevents collapse of unstable alveoli and over time recruits additional alveolar units in the injured lung. The major difference between this mode and more conventional modes is that in APRV the mean inspiratory pressure is maximized and end-expiratory pressure is due to intentional auto-PEEP. In addition, spontaneous breathing is allowed throughout the entire cycle (Figure 2).13

Although APRV does not approximate the physiology of spontaneous breathing with healthy lungs, it is nonetheless relatively comfortable and well tolerated. Its theoretical advantage in patients with lung injury is its ability to maximize alveoli recruitment by maintaining a higher mean inspiratory pressure, while the peak alveolar pressure remains lower than with conventional ventilation (Figure 1).

Other modes that are similar to APRV

Other modes of mechanical ventilation very similar to APRV are biphasic positive airway pressure (BiPAP) and bilevel ventilation.

BiPAP differs from APRV only in the timing of the upper and lower pressure levels. In BiPAP, T high is usually shorter than T low. Therefore, in order to avoid derecruitment, P low has to be set above zero with both a high and a low PEEP level.13

No studies have demonstrated one mode to be more beneficial than the other, although BiPAP might be more predictable, as both pressures are known.

Bilevel ventilation works like APRV but incorporates pressure support to spontaneous breathing. The use of pressure support may affect the positive physiologic effects (see section below) of unsupported spontaneous breathing. Nevertheless, this strategy might be useful to address severe hypercapnia in the context of APRV.

INITIAL VENTILATOR SETTINGS IN APRV

As we described in the previous section, P high and T high are set to increase end-inspiratory lung volume, recruitment, and oxygenation. P low and T low regulate end-expiratory lung volume, and their settings should prevent derecruitment but ensure adequate alveolar ventilation (Table 1).

P high. In selecting an initial P high, we measure the plateau pressure in a conventional mode using an accepted protective strategy, such as volume-control mode. If the plateau pressure is lower than 30 cm H2O, we use this pressure as our initial P high. If the plateau pressure is higher than 30 cm H2O, we select 30 cm H2O as an initial P high to minimize peak alveolar pressure and reduce the risk of lung overdistention.

P low is set at 0 cm H2O.

T high is set at 4 seconds and is then adjusted if necessary.

T low is probably the most difficult variable to set because it needs to be short enough to avoid derecruitment but still long enough to allow alveolar ventilation. We usually start with a T low of 0.6 to 0.8 seconds.

ADJUSTING THE VENTILATOR SETTINGS

For hypoxemia. Physician-controlled variables that affect oxygenation in APRV are:

  • Mean airway pressure (dependent primarily on P high and T high)
  • Fraction of inspired oxygen (Fio2).

Inadequate oxygenation usually requires increasing one or both of these settings.

Physician-controlled variables that affect alveolar ventilation in the APRV mode are:

  • Pressure gradient (P high minus P low)
  • Airway pressure release time (T low)
  • Airway pressure release frequency.14 Frequency is related to total cycle time of mandatory breaths by the following equation3:

frequency = 60/cycle time = 60/(T high + T low).

Note that if T low remains constant, adjusting T high will adjust frequency (the more time the lung remains inflated, the lower the respiratory frequency). Conversely, some ventilators allow adjustment of frequency, making T high the dependent variable. The goal of this mode is to recruit alveoli and improve oxygenation, so we usually do not modify the pressure gradient to improve ventilation.

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 3.
In practice, physicians rarely calculate the time constant for each patient to set T low. Hence, T low is usually adjusted according to the flow-time curve on the ventilator, so that the pressure release ends when expiratory flow reaches approximately 40% of the peak expiratory flow, ie, approximately 1 time constant (Figure 3).13

For hypercapnia. A frequent and expected consequence of lung-protective ventilation strategies is hypercapnia, termed “permissive” hypercapnia because it is allowed to some extent. In APRV, some degree of CO2 retention is not unusual. When the measured Paco2 becomes extreme, we usually increase the frequency of releases by shortening T high, recognizing that this adjustment may affect recruitment by lowering the mean airway pressure.

Spontaneous breaths. A positive aspect of APRV that contributes to its tolerability for patients is that it allows for spontaneous respiration. In some studies of patients with ARDS ventilated with APRV, spontaneous breathing accounted for 10% to 30% of the total minute ventilation and was responsible for an improvement in ventilation-perfusion matching and oxygenation.15,16 We titrate our patients’ sedation to a goal of spontaneous breathing of at least 10% of total minute ventilation.

 

 

WEANING FROM APRV

Weaning from APRV is done carefully to avoid derecruitment. Some authors recommend lowering P high by 2 to 3 cm H2O at a time and lengthening T high by increments of 0.5 to 2.0 seconds.13,17

Once P high is about 16 cm H2O, T high is at 12 to 15 seconds, and spontaneous respiration accounts for most or all of the minute volume, the mode can be changed to continuous positive airway pressure (CPAP) and titrated downwards. Usually, when CPAP is at 5 to 10 cm H2O, the patient is extubated, provided that mental status or concerns about airway protection or secretions are not contraindications.

PHYSIOLOGIC EFFECTS OF APRV WITH SPONTANEOUS BREATHING

Effects on the respiratory system

During spontaneous breathing, the greatest displacement of the diaphragm is in dependent regions. These regions are the best ventilated.18 Compared with spontaneously breathing patients, mechanically ventilated patients have a smaller inspiratory displacement of the dependent part of the lung.19

A study using computed tomography demonstrated that the reduction of lung volume observed in patients with acute lung injury (ALI) predominantly affects the lower lobes (dependent areas).20 Causative mechanisms could be an increase in lung weight related to ALI and a passive collapse of the lower lobes associated with an upward shift of the diaphragm.

In a preliminary study, the topographic distribution of lung collapse was different in spontaneously breathing ARDS patients than in patients who were paralyzed. In particular, lung densities were not concentrated in the dependent regions in the former group.21

Oxygenation is better with APRV with spontaneous breathing than with mechanical ventilation alone. This effect is at least partly attributable to recruitment of collapsed lung tissue and increased aeration of the dependent areas of the lung.22

Putensen et al15 compared ventilation-perfusion distribution in 24 patients with ARDS who were randomized to APRV with spontaneous breathing (more than 10% of the total minute ventilation), APRV without spontaneous breathing, or pressure-support ventilation. Spontaneous breathing during APRV improved ventilation-perfusion matching and increased systemic blood flow.

Neumann et al23 recently compared the effect of APRV with spontaneous breathing vs APRV without spontaneous breathing in terms of ventilation perfusion in an animal model of lung injury. APRV with spontaneous breathing increased ventilation in juxta-diaphragmatic regions, predominantly in dependent areas. Spontaneous breathing had a significant effect on the spatial distribution of ventilation and pulmonary perfusion.

Based on these studies, we generally use APRV with no pressure support. This strategy permits recruitment and expansion of dependent lung areas.

Effects on the cardiovascular system and hemodynamics

Räsänen et al,24 in an animal model, compared cardiovascular performance during APRV, spontaneous breathing, and continuous positive pressure ventilation. No significant differences in cardiovascular function were detected between APRV and spontaneous breathing. In contrast, continuous positive pressure ventilation decreased blood pressure, stroke volume, cardiac output, and oxygen delivery.

Falkenhain et al,25 in a subsequent case report, found that a change in mode from intermittent mandatory ventilation with PEEP to APRV resulted in improvement in the cardiac output of a patient requiring mechanical ventilation.

The lack of deleterious effect of APRV on cardiovascular function is probably a result of its spontaneous breathing component. The reduction in mean intrathoracic pressure during spontaneous breathing (compared to paralysis) improves venous return and biventricular filling, boosting cardiac output and oxygen delivery.26

Hering et al27 compared APRV with spontaneous breathing (at least 30% of the total minute ventilation) vs APRV with no spontaneous breathing in 12 patients with ALI. This study showed higher renal blood flow, glomerular filtration, and osmolar clearance in the APRV-with-spontaneous-breathing group.

The same investigators evaluated the effects of spontaneous breathing with APRV on intestinal blood flow in an animal model of lung injury.28 Spontaneous breathing with APRV improved arterial oxygenation, the systemic hemodynamic profile, and regional perfusion to the stomach and small bowel compared with full ventilatory support.

ANIMAL STUDIES OF APRV

Stock et al,11 in their original description of APRV in 1987, reported experimental results in dogs. In that study, 10 dogs with and without ARDS were randomized to APRV with a custom-built device vs volume-control mode with a Harvard pump ventilator plus PEEP. APRV delivered adequate alveolar ventilation, had lower peak airway pressures, and promoted better arterial oxygenation (at the same tidal volume and mean airway pressure) compared with volume control.

Martin et al (1991)29 studied seven neonatal lambs with ALI with four ventilatory modes: pressure-support ventilation, APRV, volume control, and spontaneous breathing. APRV maintained oxygenation while augmenting alveolar ventilation compared with pressure-support ventilation. APRV also provided ventilation at a lower peak pressure in contrast to volume control. The authors concluded that APRV was an effective mode to maintain oxygenation and assist alveolar ventilation with minimal cardiovascular impact in their animal model of ALI.

 

 

HUMAN STUDIES OF APRV

Garner et al (1988)30 studied 14 patients after operative coronary revascularization, giving them volume control mode (12 mL/kg) and then, when they were hemodynamically stable, APRV. While APRV and volume control supported ventilation and arterial oxygenation equally in all cases, peak airway pressure was greater with volume control.

Räsänen et al (1991)31 designed a prospective, multicenter, crossover trial in which 50 patients with ALI were ventilated with conventional ventilation and subsequently with APRV. Patients in both groups were adequately ventilated and oxygenated. However, as described in the aforementioned study,24 the peak airway pressure was lower in the APRV group.

Davis et al (1993)32 studied 15 patients with ARDS requiring ventilatory support who received intermittent mandatory ventilation plus PEEP and then were placed on APRV. Peak airway pressure was lower, but mean airway pressure was higher with APRV. There were no statistically significant differences in gas exchange or hemodynamic variables.

Putensen et al,33 in a study designed on the basis of prior publications,15 randomized 30 patients with multiple trauma to either APRV with spontaneous breathing (n = 15) or pressure-control ventilation (n = 15) for 72 hours. Weaning was performed with APRV in both groups. APRV was associated with increases in lung compliance and oxygenation and reduction of shunting. Interestingly, the use of APRV was associated with shorter duration of ventilatory support (15 vs 21 days), shorter length of intensive care unit stay (23 vs 30 days), and shorter duration of sedation and use of vasopressors.

An important confounder in this trial was that all patients on pressure-control ventilation were initially paralyzed, favoring the APRV group.

Varpula and colleagues34 performed a prospective randomized intervention study to determine whether the response of oxygenation to the prone position differed between APRV vs pressure-controlled synchronized intermittent mandatory ventilation with pressure support. Forty-five patients with ALI were randomized within 72 hours of initiation of mechanical ventilation to receive one of these two modes; 33 ultimately received the assigned treatment. All patients were positioned on their stomachs for 6 hours once or twice a day. The response in terms of oxygenation to the first pronation was similar in both groups, whereas there was a significant improvement after the second pronation in the APRV group. The authors concluded that prone positioning and allowance of spontaneous breathing during APRV had advantageous effects on gas exchange.

In 2004, the same investigators35 randomized 58 patients with ALI after stabilization to either APRV or pressure-controlled synchronized intermittent mandatory ventilation. There were no significant differences in the clinically important outcomes such as ventilator-free days, sedation days, need of hemodialysis, or intensive care unit-free days.

Dart et al,36 in a retrospective study of 46 trauma patients who were ventilated with APRV for 72 hours, found an improvement in the Pao2/Fio2 ratio and a decrement in peak airway pressure after APRV was started.

In conclusion, most studies show physiologic benefits and improvement in some clinical outcomes, such as oxygenation, use of sedation, hemodynamic variables, and respiratory mechanics. However, no studies report that APRV decreases the mortality rate compared with conventional protective ventilation.

Table 2 summarizes the randomized clinical trials of APRV.33–35,37

CONCERNS ABOUT APRV

Overstretching. One of the major concerns when applying APRV is overstretching the lung parenchyma.26,38 It is important to recognize that, when choosing a P high setting, this variable is not the only determinant of the tidal volume. Spontaneous breathing causes the pleural pressure to become less positive. As a result, there is an increase in the transpulmonary pressure (pressure in alveoli minus pressure in the pleura). This augmentation of transpulmonary pressure will result in a higher tidal volume and the risk of overdistention and volume-induced lung injury.

Atelectrauma. As mentioned earlier, damage may occur when airways open and close with each tidal cycle. This is particularly worrisome when the end-expiratory pressure is below the lower inflection point, as some diseased alveolar units may collapse. In APRV, the airway pressure is released to zero. Even though the intentional auto-PEEP might maintain a certain end-expiratory pressure, this parameter is truly uncontrolled.39

If the patient cannot breath spontaneously. Another consideration is that many of the benefits of APRV are based on the spontaneous breathing component. Unfortunately, patients who need heavy sedation or neuromuscular paralysis with lack of spontaneous breathing efforts may lose the physiologic advantages of this mode.

Possible contraindications to APRV include conditions that may worsen with the elevation of the mean airway pressure, such as unmanaged increases of intracranial pressure and large bronchopleural fistulas.

Despite these limitations, APRV presents many attractive benefits as an alternative mode of mechanical ventilation in patients who do not respond to conventional modes.

Table 3 summarizes the advantages and disadvantages of each component of APRV.

In the early stages of acute respiratory distress syndrome (ARDS), multiple areas of the lung collapse, most often in the dependent regions. A factor involved in this process is the loss of functional surfactant, creating a condition in which alveolar units are unstable and prone to collapse due to unopposed surface tension. This situation, similar to that in premature infants, results in a reduced volume of aerated lung, intrapulmonary shunting, and, therefore, poor oxygenation.

The treatment of this alveolar collapse is lung reinflation (or “recruitment,” a term first used by Lachmann).1 Gattinoni et al2 showed that the percentage of recruitable lung could range from a negligible fraction to 50% or more.

There are various means of reopening injured lungs and keeping them open. The choice of recruitment maneuver is based on the individual patient and the ventilatory mode.3

In this article, we review airway pressure release ventilation (APRV), a mode of mechanical ventilation that may be useful in situations in which, due to ARDS, the lungs need to be recruited and held open. APRV was developed as a lung-protective mode, allowing recruitment while minimizing ventilator-induced lung injury.

BASIC PRINCIPLES OF PROTECTIVE VENTILATION

Figure 1.
If we draw a graph with the pressure in the lung on the horizontal axis and the volume on the vertical axis, the result is called the compliance curve (Figure 1).

This curve has two inflection points between which its slope is steep, indicating greater compliance or elasticity. Below the lower inflection point, the alveoli may collapse; above the upper inflection point, the lung loses its elastic properties and the alveoli are overdistended. To protect the lungs, the challenge in mechanical ventilation is to keep the lungs between these two points throughout the respiratory cycle.

Avoiding lung collapse by using PEEP

During mechanical ventilation, the pressure in the lungs is lowest, and thus the alveoli are most prone to collapse, at the end of expiration.

We want to prevent the alveoli from collapsing with each expiration and reopening with each inspiration, as this cycle of opening and closing damages them (causing atelectrauma, ie, cyclical atelectasis).4 Preventing it prevents the release of inflammatory mediators and the perpetuation of lung injury (biotrauma).5

The solution is to apply positive end-expiratory pressure (PEEP), taking into account the value of the lower inflection point when setting the PEEP level.

Villar et al6 compared outcomes in an intervention group that received a PEEP level 2 cm H2O above the lower inflection point plus low tidal volumes, and in a control group that received higher tidal volumes and low PEEP (5 cm H2O). The study was stopped early, after significantly more patients had died in the control group than in the intervention group (53% vs 32%, P = .04).

Avoiding overdistention by keeping the tidal volume low

Tidal volumes that exceed the upper inflection point overstretch the lung and induce volutrauma, which can manifest as pneumothorax or pneumomediastinum, or both—the lungs rupture like a balloon. Also, overdistention produces liberation of inflammatory mediators in the blood (biotrauma). High tidal volumes should therefore be avoided or limited as much as possible.

The ARDS Network,7 in a multicenter, randomized, controlled trial, showed that fewer patients die if they receive mechanical ventilation with low tidal volumes rather than higher, “conventional” tidal volumes. Patients were randomized to receive either a tidal volume of 6 mL/kg and a plateau pressure lower than 30 cm H2O or a tidal volume of 12 mL/kg and a plateau pressure lower than 50 cm H2O. They were followed for 180 days or until discharged home, breathing without assistance. A total of 861 patients were enrolled. The mortality rate was significantly lower in the low tidal volume group than in the group with conventional tidal volumes, 31% vs 40%.

Lower tidal volumes were also associated with faster attenuation of the inflammatory response.8

Amato et al9 randomized 58 patients to receive mechanical ventilation with tidal volumes of either 6 mL/kg or 12 mL/kg. The PEEP level was maintained above the lower inflection point. At 28 days, 62% of the patients in the intervention group were still alive, compared with only 29% in the control group. However, many concerns were expressed over the high mortality rate in the control group.

Based on these studies, the use of low tidal volumes with appropriate levels of PEEP to ensure lung recruitment is the current standard of care in mechanical ventilation of patients with ARDS.10

 

 

APRV: A PRESSURE-CONTROLLED MODE THAT ALLOWS SPONTANEOUS BREATHS

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 2.
Airway pressure release ventilation (APRV), first described by Stock et al in 1987,11 is essentially a pressure-control mode—ie, the clinician sets a high and a low pressure. However, it also allows spontaneous breathing through the entire breathing cycle (Figure 2).12,13

A baseline high pressure (P high) is set first. Mandatory breaths are achieved by releasing the high baseline pressure in the circuit very briefly, usually to 0 cm H2O (P low), which allows the lungs to partially deflate, and then quickly resuming the high pressure before the unstable alveoli can collapse.

In theory, the optimal release time (the very short time in low pressure, or T low) in APRV should be determined by the time constant of the expiratory flow. The time constant (t) is the time it takes to empty 63% of the lung volume. It is calculated as:

t = C × R

where C is the combined compliance of the lung and chest wall, and R is the combined resistance of the endotracheal tube and the natural airways. In diseases that lead to lower lung compliance (such as ARDS), the time constant is shorter. A practical equilibrium time—or the time it takes for the lung volume in expiration to reach steady state (no expiratory flow)—is about 4 time constants.14

Since the release time in APRV is much shorter than the equilibrium time, a residual volume of air remains in the lung, creating intentional auto-PEEP. Ideally, this intentional auto-PEEP should be high enough to avoid derecruitment (optimally above the lower inflection point). In APRV the auto-PEEP is controlled by the settings, and this intentional restriction of the expiratory flow is critical to avoid derecruitment of unstable alveolar units.

The amount of time spent at the higher pressure (T high) is generally 80% to 95% of the cycle (ie, the lungs are “inflated” 80% to 95% of the time), and the amount of time at the lower pressure (T low) is 0.6 to 0.8 seconds.

Thus, APRV settings provide a relatively high mean airway pressure, which prevents collapse of unstable alveoli and over time recruits additional alveolar units in the injured lung. The major difference between this mode and more conventional modes is that in APRV the mean inspiratory pressure is maximized and end-expiratory pressure is due to intentional auto-PEEP. In addition, spontaneous breathing is allowed throughout the entire cycle (Figure 2).13

Although APRV does not approximate the physiology of spontaneous breathing with healthy lungs, it is nonetheless relatively comfortable and well tolerated. Its theoretical advantage in patients with lung injury is its ability to maximize alveoli recruitment by maintaining a higher mean inspiratory pressure, while the peak alveolar pressure remains lower than with conventional ventilation (Figure 1).

Other modes that are similar to APRV

Other modes of mechanical ventilation very similar to APRV are biphasic positive airway pressure (BiPAP) and bilevel ventilation.

BiPAP differs from APRV only in the timing of the upper and lower pressure levels. In BiPAP, T high is usually shorter than T low. Therefore, in order to avoid derecruitment, P low has to be set above zero with both a high and a low PEEP level.13

No studies have demonstrated one mode to be more beneficial than the other, although BiPAP might be more predictable, as both pressures are known.

Bilevel ventilation works like APRV but incorporates pressure support to spontaneous breathing. The use of pressure support may affect the positive physiologic effects (see section below) of unsupported spontaneous breathing. Nevertheless, this strategy might be useful to address severe hypercapnia in the context of APRV.

INITIAL VENTILATOR SETTINGS IN APRV

As we described in the previous section, P high and T high are set to increase end-inspiratory lung volume, recruitment, and oxygenation. P low and T low regulate end-expiratory lung volume, and their settings should prevent derecruitment but ensure adequate alveolar ventilation (Table 1).

P high. In selecting an initial P high, we measure the plateau pressure in a conventional mode using an accepted protective strategy, such as volume-control mode. If the plateau pressure is lower than 30 cm H2O, we use this pressure as our initial P high. If the plateau pressure is higher than 30 cm H2O, we select 30 cm H2O as an initial P high to minimize peak alveolar pressure and reduce the risk of lung overdistention.

P low is set at 0 cm H2O.

T high is set at 4 seconds and is then adjusted if necessary.

T low is probably the most difficult variable to set because it needs to be short enough to avoid derecruitment but still long enough to allow alveolar ventilation. We usually start with a T low of 0.6 to 0.8 seconds.

ADJUSTING THE VENTILATOR SETTINGS

For hypoxemia. Physician-controlled variables that affect oxygenation in APRV are:

  • Mean airway pressure (dependent primarily on P high and T high)
  • Fraction of inspired oxygen (Fio2).

Inadequate oxygenation usually requires increasing one or both of these settings.

Physician-controlled variables that affect alveolar ventilation in the APRV mode are:

  • Pressure gradient (P high minus P low)
  • Airway pressure release time (T low)
  • Airway pressure release frequency.14 Frequency is related to total cycle time of mandatory breaths by the following equation3:

frequency = 60/cycle time = 60/(T high + T low).

Note that if T low remains constant, adjusting T high will adjust frequency (the more time the lung remains inflated, the lower the respiratory frequency). Conversely, some ventilators allow adjustment of frequency, making T high the dependent variable. The goal of this mode is to recruit alveoli and improve oxygenation, so we usually do not modify the pressure gradient to improve ventilation.

Reprinted from Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clinical Issues 2001; 12:234–246, with permission from Wolters Kluwer Health/Lippincott, Williams &amp; Wilkins.
Figure 3.
In practice, physicians rarely calculate the time constant for each patient to set T low. Hence, T low is usually adjusted according to the flow-time curve on the ventilator, so that the pressure release ends when expiratory flow reaches approximately 40% of the peak expiratory flow, ie, approximately 1 time constant (Figure 3).13

For hypercapnia. A frequent and expected consequence of lung-protective ventilation strategies is hypercapnia, termed “permissive” hypercapnia because it is allowed to some extent. In APRV, some degree of CO2 retention is not unusual. When the measured Paco2 becomes extreme, we usually increase the frequency of releases by shortening T high, recognizing that this adjustment may affect recruitment by lowering the mean airway pressure.

Spontaneous breaths. A positive aspect of APRV that contributes to its tolerability for patients is that it allows for spontaneous respiration. In some studies of patients with ARDS ventilated with APRV, spontaneous breathing accounted for 10% to 30% of the total minute ventilation and was responsible for an improvement in ventilation-perfusion matching and oxygenation.15,16 We titrate our patients’ sedation to a goal of spontaneous breathing of at least 10% of total minute ventilation.

 

 

WEANING FROM APRV

Weaning from APRV is done carefully to avoid derecruitment. Some authors recommend lowering P high by 2 to 3 cm H2O at a time and lengthening T high by increments of 0.5 to 2.0 seconds.13,17

Once P high is about 16 cm H2O, T high is at 12 to 15 seconds, and spontaneous respiration accounts for most or all of the minute volume, the mode can be changed to continuous positive airway pressure (CPAP) and titrated downwards. Usually, when CPAP is at 5 to 10 cm H2O, the patient is extubated, provided that mental status or concerns about airway protection or secretions are not contraindications.

PHYSIOLOGIC EFFECTS OF APRV WITH SPONTANEOUS BREATHING

Effects on the respiratory system

During spontaneous breathing, the greatest displacement of the diaphragm is in dependent regions. These regions are the best ventilated.18 Compared with spontaneously breathing patients, mechanically ventilated patients have a smaller inspiratory displacement of the dependent part of the lung.19

A study using computed tomography demonstrated that the reduction of lung volume observed in patients with acute lung injury (ALI) predominantly affects the lower lobes (dependent areas).20 Causative mechanisms could be an increase in lung weight related to ALI and a passive collapse of the lower lobes associated with an upward shift of the diaphragm.

In a preliminary study, the topographic distribution of lung collapse was different in spontaneously breathing ARDS patients than in patients who were paralyzed. In particular, lung densities were not concentrated in the dependent regions in the former group.21

Oxygenation is better with APRV with spontaneous breathing than with mechanical ventilation alone. This effect is at least partly attributable to recruitment of collapsed lung tissue and increased aeration of the dependent areas of the lung.22

Putensen et al15 compared ventilation-perfusion distribution in 24 patients with ARDS who were randomized to APRV with spontaneous breathing (more than 10% of the total minute ventilation), APRV without spontaneous breathing, or pressure-support ventilation. Spontaneous breathing during APRV improved ventilation-perfusion matching and increased systemic blood flow.

Neumann et al23 recently compared the effect of APRV with spontaneous breathing vs APRV without spontaneous breathing in terms of ventilation perfusion in an animal model of lung injury. APRV with spontaneous breathing increased ventilation in juxta-diaphragmatic regions, predominantly in dependent areas. Spontaneous breathing had a significant effect on the spatial distribution of ventilation and pulmonary perfusion.

Based on these studies, we generally use APRV with no pressure support. This strategy permits recruitment and expansion of dependent lung areas.

Effects on the cardiovascular system and hemodynamics

Räsänen et al,24 in an animal model, compared cardiovascular performance during APRV, spontaneous breathing, and continuous positive pressure ventilation. No significant differences in cardiovascular function were detected between APRV and spontaneous breathing. In contrast, continuous positive pressure ventilation decreased blood pressure, stroke volume, cardiac output, and oxygen delivery.

Falkenhain et al,25 in a subsequent case report, found that a change in mode from intermittent mandatory ventilation with PEEP to APRV resulted in improvement in the cardiac output of a patient requiring mechanical ventilation.

The lack of deleterious effect of APRV on cardiovascular function is probably a result of its spontaneous breathing component. The reduction in mean intrathoracic pressure during spontaneous breathing (compared to paralysis) improves venous return and biventricular filling, boosting cardiac output and oxygen delivery.26

Hering et al27 compared APRV with spontaneous breathing (at least 30% of the total minute ventilation) vs APRV with no spontaneous breathing in 12 patients with ALI. This study showed higher renal blood flow, glomerular filtration, and osmolar clearance in the APRV-with-spontaneous-breathing group.

The same investigators evaluated the effects of spontaneous breathing with APRV on intestinal blood flow in an animal model of lung injury.28 Spontaneous breathing with APRV improved arterial oxygenation, the systemic hemodynamic profile, and regional perfusion to the stomach and small bowel compared with full ventilatory support.

ANIMAL STUDIES OF APRV

Stock et al,11 in their original description of APRV in 1987, reported experimental results in dogs. In that study, 10 dogs with and without ARDS were randomized to APRV with a custom-built device vs volume-control mode with a Harvard pump ventilator plus PEEP. APRV delivered adequate alveolar ventilation, had lower peak airway pressures, and promoted better arterial oxygenation (at the same tidal volume and mean airway pressure) compared with volume control.

Martin et al (1991)29 studied seven neonatal lambs with ALI with four ventilatory modes: pressure-support ventilation, APRV, volume control, and spontaneous breathing. APRV maintained oxygenation while augmenting alveolar ventilation compared with pressure-support ventilation. APRV also provided ventilation at a lower peak pressure in contrast to volume control. The authors concluded that APRV was an effective mode to maintain oxygenation and assist alveolar ventilation with minimal cardiovascular impact in their animal model of ALI.

 

 

HUMAN STUDIES OF APRV

Garner et al (1988)30 studied 14 patients after operative coronary revascularization, giving them volume control mode (12 mL/kg) and then, when they were hemodynamically stable, APRV. While APRV and volume control supported ventilation and arterial oxygenation equally in all cases, peak airway pressure was greater with volume control.

Räsänen et al (1991)31 designed a prospective, multicenter, crossover trial in which 50 patients with ALI were ventilated with conventional ventilation and subsequently with APRV. Patients in both groups were adequately ventilated and oxygenated. However, as described in the aforementioned study,24 the peak airway pressure was lower in the APRV group.

Davis et al (1993)32 studied 15 patients with ARDS requiring ventilatory support who received intermittent mandatory ventilation plus PEEP and then were placed on APRV. Peak airway pressure was lower, but mean airway pressure was higher with APRV. There were no statistically significant differences in gas exchange or hemodynamic variables.

Putensen et al,33 in a study designed on the basis of prior publications,15 randomized 30 patients with multiple trauma to either APRV with spontaneous breathing (n = 15) or pressure-control ventilation (n = 15) for 72 hours. Weaning was performed with APRV in both groups. APRV was associated with increases in lung compliance and oxygenation and reduction of shunting. Interestingly, the use of APRV was associated with shorter duration of ventilatory support (15 vs 21 days), shorter length of intensive care unit stay (23 vs 30 days), and shorter duration of sedation and use of vasopressors.

An important confounder in this trial was that all patients on pressure-control ventilation were initially paralyzed, favoring the APRV group.

Varpula and colleagues34 performed a prospective randomized intervention study to determine whether the response of oxygenation to the prone position differed between APRV vs pressure-controlled synchronized intermittent mandatory ventilation with pressure support. Forty-five patients with ALI were randomized within 72 hours of initiation of mechanical ventilation to receive one of these two modes; 33 ultimately received the assigned treatment. All patients were positioned on their stomachs for 6 hours once or twice a day. The response in terms of oxygenation to the first pronation was similar in both groups, whereas there was a significant improvement after the second pronation in the APRV group. The authors concluded that prone positioning and allowance of spontaneous breathing during APRV had advantageous effects on gas exchange.

In 2004, the same investigators35 randomized 58 patients with ALI after stabilization to either APRV or pressure-controlled synchronized intermittent mandatory ventilation. There were no significant differences in the clinically important outcomes such as ventilator-free days, sedation days, need of hemodialysis, or intensive care unit-free days.

Dart et al,36 in a retrospective study of 46 trauma patients who were ventilated with APRV for 72 hours, found an improvement in the Pao2/Fio2 ratio and a decrement in peak airway pressure after APRV was started.

In conclusion, most studies show physiologic benefits and improvement in some clinical outcomes, such as oxygenation, use of sedation, hemodynamic variables, and respiratory mechanics. However, no studies report that APRV decreases the mortality rate compared with conventional protective ventilation.

Table 2 summarizes the randomized clinical trials of APRV.33–35,37

CONCERNS ABOUT APRV

Overstretching. One of the major concerns when applying APRV is overstretching the lung parenchyma.26,38 It is important to recognize that, when choosing a P high setting, this variable is not the only determinant of the tidal volume. Spontaneous breathing causes the pleural pressure to become less positive. As a result, there is an increase in the transpulmonary pressure (pressure in alveoli minus pressure in the pleura). This augmentation of transpulmonary pressure will result in a higher tidal volume and the risk of overdistention and volume-induced lung injury.

Atelectrauma. As mentioned earlier, damage may occur when airways open and close with each tidal cycle. This is particularly worrisome when the end-expiratory pressure is below the lower inflection point, as some diseased alveolar units may collapse. In APRV, the airway pressure is released to zero. Even though the intentional auto-PEEP might maintain a certain end-expiratory pressure, this parameter is truly uncontrolled.39

If the patient cannot breath spontaneously. Another consideration is that many of the benefits of APRV are based on the spontaneous breathing component. Unfortunately, patients who need heavy sedation or neuromuscular paralysis with lack of spontaneous breathing efforts may lose the physiologic advantages of this mode.

Possible contraindications to APRV include conditions that may worsen with the elevation of the mean airway pressure, such as unmanaged increases of intracranial pressure and large bronchopleural fistulas.

Despite these limitations, APRV presents many attractive benefits as an alternative mode of mechanical ventilation in patients who do not respond to conventional modes.

Table 3 summarizes the advantages and disadvantages of each component of APRV.

References
  1. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18:319321.
  2. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:17751786.
  3. Papadakos PJ, Lachmann B. The open lung concept of mechanical ventilation: the role of recruitment and stabilization. Crit Care Clin 2007; 23:241250,
  4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:13341349.
  5. Dreyfuss D, Saumon G, Hubmayr RD, editors. Ventilator-induced Lung Injury. New York: Taylor & Francis, 2006.
  6. Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34:13111318.
  7. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:13011308.
  8. Parsons PE, Eisner MD, Thompson BT, et al; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:16.
  9. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347354.
  10. Hemmila MR, Napolitano LM. Severe respiratory failure: advanced treatment options. Crit Care Med 2006; 34( suppl 9):S278S290.
  11. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med 1987; 15:462466.
  12. Chatburn RL. Classification of ventilator modes: update and proposal for implementation. Respir Care 2007; 52:301323.
  13. Martin LD, Wetzel RC. Optimal release time during airway pressure release ventilation in neonatal sheep. Crit Care Med 1994; 22:486493.
  14. Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clin Issues 2001; 12:234246.
  15. Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:12411248.
  16. Putensen C, Wrigge H. Clinical review: biphasic positive airway pressure and airway pressure release ventilation. Crit Care 2004; 8:492497.
  17. Habashi NM. Other approaches to open-lung ventilation: airway pressure release ventilation. Crit Care Med 2005; 33( suppl 3):S228S240.
  18. Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41:242255.
  19. Reber A, Nylund U, Hedenstierna G. Position and shape of the diaphragm: implications for atelectasis formation. Anaesthesia 1998; 53:10541061.
  20. Puybasset L, Cluzel P, Chao N, Slutsky AS, Coriat P, Rouby JJ. A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group. Am J Respir Crit Care Med 1998; 158:16441655.
  21. Gattinoni L, Presenti A, Torresin A, et al. Adult respiratory distress syndrome profiles by computed tomography. J Thorac Imaging 1986; 1:2530.
  22. Hedenstierna G, Lichtwarck-Aschoff M. Interfacing spontaneous breathing and mechanical ventilation. New insights. Minerva Anestesiol 2006; 72:183198.
  23. Neumann P, Wrigge H, Zinserling J, et al. Spontaneous breathing affects the spatial ventilation and perfusion distribution during mechanical ventilatory support. Crit Care Med 2005; 33:10901095.
  24. Räsänen J, Downs JB, Stock MC. Cardiovascular effects of conventional positive pressure ventilation and airway pressure release ventilation. Chest 1988; 93:911915.
  25. Falkenhain SK, Reilley TE, Gregory JS. Improvement in cardiac output during airway pressure release ventilation. Crit Care Med 1992; 20:13581360.
  26. Siau C, Stewart TE. Current role of high frequency oscillatory ventilation and airway pressure release ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2008; 29:265275.
  27. Hering R, Peters D, Zinserling J, Wrigge H, von Spiegel T, Putensen C. Effects of spontaneous breathing during airway pressure release ventilation on renal perfusion and function in patients with acute lung injury. Intensive Care Med 2002; 28:14261433.
  28. Hering R, Viehöfer A, Zinserling J, et al. Effects of spontaneous breathing during airway pressure release ventilation on intestinal blood flow in experimental lung injury. Anesthesiology 2003; 99:11371144.
  29. Martin LD, Wetzel RC, Bilenki AL. Airway pressure release ventilation in a neonatal lamb model of acute lung injury. Crit Care Med 1991; 19:373378.
  30. Garner W, Downs JB, Stock MC, Räsänen J. Airway pressure release ventilation (APRV). A human trial. Chest 1988; 94:779781.
  31. Räsänen J, Cane RD, Downs JB, et al. Airway pressure release ventilation during acute lung injury: a prospective multicenter trial. Crit Care Med 1991; 19:12341241.
  32. Davis K, Johnson DJ, Branson RD, Campbell RS, Johannigman JA, Porembka D. Airway pressure release ventilation. Arch Surg 1993; 128:13481352.
  33. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001; 164:4349.
  34. Varpula T, Jousela I, Niemi R, Takkunen O, Pettilä V. Combined effects of prone positioning and airway pressure release ventilation on gas exchange in patients with acute lung injury. Acta Anaesthesiol Scand 2003; 47:516524.
  35. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004; 48:722731.
  36. Dart BW, Maxwell RA, Richart CM, et al. Preliminary experience with airway pressure release ventilation in a trauma/surgical intensive care unit. J Trauma 2005; 59:7176.
  37. Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-term effects of two different ventilatory modes on oxygenation in acute lung injury. Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation. Am J Respir Crit Care Med 1994; 149:15501556.
  38. Neumann P, Golisch W, Strohmeyer A, Buscher H, Burchardi H, Sydow M. Influence of different release times on spontaneous breathing pattern during airway pressure release ventilation. Intensive Care Med 2002; 28:17421749.
  39. Dries DJ, Marini JJ. Airway pressure release ventilation. J Burn Care Res 2009; 30:929936.
References
  1. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992; 18:319321.
  2. Gattinoni L, Caironi P, Cressoni M, et al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006; 354:17751786.
  3. Papadakos PJ, Lachmann B. The open lung concept of mechanical ventilation: the role of recruitment and stabilization. Crit Care Clin 2007; 23:241250,
  4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:13341349.
  5. Dreyfuss D, Saumon G, Hubmayr RD, editors. Ventilator-induced Lung Injury. New York: Taylor & Francis, 2006.
  6. Villar J, Kacmarek RM, Pérez-Méndez L, Aguirre-Jaime A. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006; 34:13111318.
  7. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:13011308.
  8. Parsons PE, Eisner MD, Thompson BT, et al; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:16.
  9. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347354.
  10. Hemmila MR, Napolitano LM. Severe respiratory failure: advanced treatment options. Crit Care Med 2006; 34( suppl 9):S278S290.
  11. Stock MC, Downs JB, Frolicher DA. Airway pressure release ventilation. Crit Care Med 1987; 15:462466.
  12. Chatburn RL. Classification of ventilator modes: update and proposal for implementation. Respir Care 2007; 52:301323.
  13. Martin LD, Wetzel RC. Optimal release time during airway pressure release ventilation in neonatal sheep. Crit Care Med 1994; 22:486493.
  14. Frawley PM, Habashi NM. Airway pressure release ventilation: theory and practice. AACN Clin Issues 2001; 12:234246.
  15. Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 159:12411248.
  16. Putensen C, Wrigge H. Clinical review: biphasic positive airway pressure and airway pressure release ventilation. Crit Care 2004; 8:492497.
  17. Habashi NM. Other approaches to open-lung ventilation: airway pressure release ventilation. Crit Care Med 2005; 33( suppl 3):S228S240.
  18. Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41:242255.
  19. Reber A, Nylund U, Hedenstierna G. Position and shape of the diaphragm: implications for atelectasis formation. Anaesthesia 1998; 53:10541061.
  20. Puybasset L, Cluzel P, Chao N, Slutsky AS, Coriat P, Rouby JJ. A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group. Am J Respir Crit Care Med 1998; 158:16441655.
  21. Gattinoni L, Presenti A, Torresin A, et al. Adult respiratory distress syndrome profiles by computed tomography. J Thorac Imaging 1986; 1:2530.
  22. Hedenstierna G, Lichtwarck-Aschoff M. Interfacing spontaneous breathing and mechanical ventilation. New insights. Minerva Anestesiol 2006; 72:183198.
  23. Neumann P, Wrigge H, Zinserling J, et al. Spontaneous breathing affects the spatial ventilation and perfusion distribution during mechanical ventilatory support. Crit Care Med 2005; 33:10901095.
  24. Räsänen J, Downs JB, Stock MC. Cardiovascular effects of conventional positive pressure ventilation and airway pressure release ventilation. Chest 1988; 93:911915.
  25. Falkenhain SK, Reilley TE, Gregory JS. Improvement in cardiac output during airway pressure release ventilation. Crit Care Med 1992; 20:13581360.
  26. Siau C, Stewart TE. Current role of high frequency oscillatory ventilation and airway pressure release ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2008; 29:265275.
  27. Hering R, Peters D, Zinserling J, Wrigge H, von Spiegel T, Putensen C. Effects of spontaneous breathing during airway pressure release ventilation on renal perfusion and function in patients with acute lung injury. Intensive Care Med 2002; 28:14261433.
  28. Hering R, Viehöfer A, Zinserling J, et al. Effects of spontaneous breathing during airway pressure release ventilation on intestinal blood flow in experimental lung injury. Anesthesiology 2003; 99:11371144.
  29. Martin LD, Wetzel RC, Bilenki AL. Airway pressure release ventilation in a neonatal lamb model of acute lung injury. Crit Care Med 1991; 19:373378.
  30. Garner W, Downs JB, Stock MC, Räsänen J. Airway pressure release ventilation (APRV). A human trial. Chest 1988; 94:779781.
  31. Räsänen J, Cane RD, Downs JB, et al. Airway pressure release ventilation during acute lung injury: a prospective multicenter trial. Crit Care Med 1991; 19:12341241.
  32. Davis K, Johnson DJ, Branson RD, Campbell RS, Johannigman JA, Porembka D. Airway pressure release ventilation. Arch Surg 1993; 128:13481352.
  33. Putensen C, Zech S, Wrigge H, et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001; 164:4349.
  34. Varpula T, Jousela I, Niemi R, Takkunen O, Pettilä V. Combined effects of prone positioning and airway pressure release ventilation on gas exchange in patients with acute lung injury. Acta Anaesthesiol Scand 2003; 47:516524.
  35. Varpula T, Valta P, Niemi R, Takkunen O, Hynynen M, Pettilä VV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand 2004; 48:722731.
  36. Dart BW, Maxwell RA, Richart CM, et al. Preliminary experience with airway pressure release ventilation in a trauma/surgical intensive care unit. J Trauma 2005; 59:7176.
  37. Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-term effects of two different ventilatory modes on oxygenation in acute lung injury. Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation. Am J Respir Crit Care Med 1994; 149:15501556.
  38. Neumann P, Golisch W, Strohmeyer A, Buscher H, Burchardi H, Sydow M. Influence of different release times on spontaneous breathing pattern during airway pressure release ventilation. Intensive Care Med 2002; 28:17421749.
  39. Dries DJ, Marini JJ. Airway pressure release ventilation. J Burn Care Res 2009; 30:929936.
Issue
Cleveland Clinic Journal of Medicine - 78(2)
Issue
Cleveland Clinic Journal of Medicine - 78(2)
Page Number
101-110
Page Number
101-110
Publications
Publications
Topics
Article Type
Display Headline
Airway pressure release ventilation: An alternative mode of mechanical ventilation in acute respiratory distress syndrome
Display Headline
Airway pressure release ventilation: An alternative mode of mechanical ventilation in acute respiratory distress syndrome
Sections
Inside the Article

KEY POINTS

  • The advantages and disadvantages of APRV are related to its two components: high mean airway pressure and spontaneous ventilation.
  • Several studies show APRV to have physiologic benefits and to improve some measures of clinical outcome, such as oxygenation, use of sedation, hemodynamics, and respiratory mechanics.
  • No study has reported that fewer patients die if they receive APRV compared with conventional protective ventilation.
  • APRV is a promising mode, and further research is needed to strengthen support for its more widespread use.
Disallow All Ads
Alternative CME
Article PDF Media